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Abstract 
Breast cancer is a heterogeneous disease with a high degree of intra- and intertumoral 
diversity, which impedes accurate patient stratification, prognosis and optimal treatment. The 
mammary gland consists of a complex network of epithelial ducts which end in clusters of 
alveoli, called terminal ductal lobular units (TDLUs) which are the functional units of the 
mammary gland. Postnatal mammary gland development and homeostasis require an 
enormous regenerative output, suggesting the existence of tissue stem/progenitor cells and a 
high degree of cellular plasticity to ensure functional robustness, i.e. the production and 
secretion of milk during lactation. Therefore, the observed heterogeneity in breast cancer is 
likely the result of normal mammary gland architecture and functionality.  
Unfortunately, the identification and characterization of human stem/progenitor cells and the 
analysis of cellular plasticity are hampered by the limited applicability of currently used 
murine in vivo assays and the failure of 2D and 3D in vitro assays to recapitulate the 
histological architecture and functionality of the human mammary gland. Organoid assays 
span the bridge between standard in vitro culture and in vivo studies by mimicking the stem 
cell niche during self-renewal or repair in 3D culture. Thereby, organoid assays support the 
formation of organoids which recapitulate the architecture and functionality of the original 
tissue. 
In this study, a novel organotypic assay was developed for the human mammary gland, in 
which single, freshly isolated human mammary epithelial cells from healthy donors cultured 
in floating collagen gels generate spheres and branched ductal structures that resemble 
TDLUs. The TDLU-like organoids were shown to form alveolar buds, express lineage 
markers at correct positions, and display functionality by contraction. In line with recent 
literature from transplantation studies, it was found that TDLU-like structure formation is 
enriched in a CD49fhi/EpCAM− population, commonly referred to as basal, while 
CD49f+/EpCAM+ LP cells predominantly formed spheres. In addition, by performing limiting 
dilution analysis, the metalloendopeptidase CD10 was revealed as marker to enrich for 
TDLU-like structure forming cells within the CD49fhi/EpCAM− population. The use of CD10 
further led to identification of stromal cells present within the CD49fhi/EpCAM− population. 
As expression of CD10 was not restricted to the CD49fhi/EpCAM− cell population, it was 
shown that a combination of all three markers is required to optimally enrich for TDLU-like 
structure forming cells. 
Importantly, the formation of TDLU-like structures was observed only in floating/compliant, 
but not in attached/rigid collagen gels and required actin-myosin-based cellular contraction. 
  
 
Structures generated in attached collagen gels exhibited aberrant marker expression and 
invasive phenotype, emphasizing the importance of physical parameters in directing 
differentiation of the mammary gland and suggesting a role in tumorigenesis. In summary this 
study describes a defined in vitro assay system to quantify mammary epithelial cells with 
regenerative potential by limiting dilution, to analyze cellular plasticity, differentiation 
potential and functionality and to systematically investigate interactions with the physical 
environment at distinct steps of morphogenesis and the effect on cell fate decisions. 
 
  
 
Zusammenfassung  
 
Brustkrebs ist durch eine hohe intra- und intertumorale Heterogenität gekennzeichnet, 
wodurch Stratifizierung sowie optimale Prognose und Behandlung von Patienten erschwert 
werden. Die adulte humane Brustdrüse besteht aus komplex verzweigten Milchgängen, 
welche in traubenartigen Strukturen, den so genannten Drüsenlappen (Terminal ductal lobular 
units, TDLUs), den funktionellen Einheiten der normalen Brustdrüse, enden. Die Entwicklung 
und Homöostase der Brustdrüse finden hauptsächlich postnatal statt und erfordern eine 
enorme regenerative Leistung, welche die Existenz von Stamm- oder Progenitorzellen sowie 
zelluläre Plastizität suggerieren, wodurch auch die Funktion der Brustdrüse, insbesondere die 
Produktion und Sekretion von Milch während der Laktation, sichergestellt werden kann.  
Die komplexe Architektur sowie der hohe regenerative Druck, dem die normale Brustdrüse 
unterliegt, spielen eine wichtige Rolle in der Heterogenität von Brustkrebs. Die heutzutage 
genutzten in vivo sowie 2D- und 3D-in vitro Modelle scheitern jedoch darin, die Architektur 
und Funktion der normalen humanen Brustdrüse korrekt nachzubilden, wodurch die 
Identifizierung und Charakterisierung von humanen Brust Stamm-/Progenitorzellen und die 
Analyse zellulärer Plastizität erschwert werden. Organoid-Ansätze bilden eine Brücke 
zwischen standard in vitro und in vivo Modellen, indem sie die Stammzellnische während der 
Gewebserneuerung/-reparatur nachbilden. Hierdurch fördern Organoid-Modelle die Bildung 
von Organoiden, die die normale Gewebearchitektur und -funktion widerspiegeln. 
In dieser Studie wurde ein neuer, organotypischer Assay für die humane Brustdrüse 
entwickelt, in dem einzelne, frisch isolierte humane Brustepithelzellen verzweigte Strukturen 
bilden, die den TDLUs ähneln. Die TDLU-ähnlichen Strukturen bilden Alveolen, exprimieren 
Zelltypmarker an den korrekten Positionen und zeigen Funktionalität, indem sie kontrahieren. 
In Übereinstimmung mit der aktuellen Literatur, basierend auf murinen 
Transplantationsstudien, konnten die TDLU-ähnliche Struktur bildenden Zellen einer 
CD49fhi/EpCAM− Population zugeordnet werden, welche als basal gilt, wohingegen gezeigt 
wurde, dass CD49f+/EpCAM+ luminale Vorläuferzellen vornehmlich Sphären bilden. Durch 
die Verwendung von „Limiting Dilution“ konnte zudem gezeigt werden, dass die Expression 
der Metalloendopeptidase CD10 die TDLU-ähnliche Struktur bildenden Zellen innerhalb der 
CD49fhi/EpCAM− Population weiter anreichert. Die Verwendung von CD10 führte außerdem 
zu der Entdeckung, dass die CD49fhi/EpCAM− Population Stromazellen enthält. Da die 
Expression von CD10 sich nicht auf die CD49fhi/EpCAM− Population beschränkt, wurde 
  
 
bestimmt, dass die Kombination der drei Marker CD49f, EpCAM und CD10 nötig ist, um 
TDLU-ähnliche Struktur bildende Zellen sauber anzureichern. 
Es ist beachtenswert, dass die Bildung von TDLU-ähnlichen Strukturen nur in 
schwimmenden/weichen Collagen-Gelen, jedoch nicht in festen/rigiden Collagen-Gelen 
beobachtet wurde, sowie Aktin-Myosin-basierte zelluläre Kontraktilität benötigte. So zeigten 
Strukturen in festen Collagen Gelen abnormale Zellmarker Expression und invasives 
Wachstum. Die physikalischen Matrixeigenschaften spielen somit eine wichtige Rolle in der 
Differenzierung der Brustdrüse und der Krebsentwicklung und können in dem hier 
präsentierten Assay nachgebildet werden. 
Zusammenfassend beschreibt diese Arbeit einen neuen organotypischen in vitro Assay, der 
die Quantifizierung von humanen Brustepithelzellen mit regenerativem Potential, die 
Erforschung von zellulärer Plastizität, Differenzierung und Funktionalität ermöglicht, sowie 
die Erforschung des Einflusses physikalischer Parameter während verschiedener Schritte der 
Morphogenese und der Differenzierung von Zellen erlaubt. 
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CO2 Carbon dioxide 
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ECM Extracellular matrix 
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Elf5 E74 like ETS transcription factor 5  
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MEK, MAPKK Mitogen-activated protein kinase kinase 
MET Mesenchymal-epithelial transition 
MG Mammary gland 
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MME Membrane metalloendopeptidase, CD10 
mRNA Messenger RNA 
n Nano 
n.a. Not applicable 
n.d. Not detectable 
n.s. Not significant 
PB Pacific blue 
PBS Phosphate-buffered saline 
PCA Principal component analysis 
PCB Primary cell buffer 
PE Phytoerythrin 
PFA Paraformaldehyde 
PI3K Phosphatidylinositol-4,5-Bisphosphate 3-Kinase 
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Popdc Popeye domain-containing protein 
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RT Room temperature 
RT-PCR Quantitative real-time polymerase chain reaction 
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s.d. Standard deviation 
SSC Side scatter 
S-SFU Sphere-structure forming unit 
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TDB Tissue digestion buffer 
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TEB Terminal end bud 
TGF-β1 Transforming growth factor beta 1 
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TNS Trypsin neutralizing solution 
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αSMA Alpha smooth muscle actin 
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Aims of the study 
 
The complex architecture and functionality of the normal mammary gland (MG) and the 
possible existence of tissue stem/progenitor cells and high cellular plasticity likely underlie 
the heterogeneity of breast cancer, which impairs accurate patient stratification, prognosis and 
optimal treatment. However, investigation of MG architecture and functionality during 
normal tissue homeostasis and disease is hampered by the fact that currently used murine in 
vivo assays and 2D and 3D in vitro assays fail to recapitulate the architecture and functionality 
of the human MG. The rationale of three-dimensional organotypic assays is to mimic the 
normal tissue environment and thereby permit formation of organoids reflecting normal MG 
architecture and function [Clevers, 2016]. Thus, the major aim of this study has been the 
development of an organotypic 3D culture model for primary human mammary epithelial 
cells, in which morphological and physiological characteristics of the human MG in situ are 
recapitulated. Collagen I is the major component of the human MG extracellular matrix in situ 
and it has previously been shown that primary human mammary organoids cultured within 
floating collagen gels generate branched structures [Foster et al., 1983]. Indeed, using floating 
collagen I gels as substrate for 3D culture allowed primary human mammary epithelial cells 
to build structures that resembled terminal ductal lobular units, the functional units of the 
human MG in situ. After improvement of culture conditions to optimally promote TDLU-like 
structure formation in floating collagen gels, the further aims of this study have been the 
development of a protocol for quantification of TDLU-like structure formation as readout for 
regenerative potential, followed by enrichment of regenerative cells and their classification 
into the basal and luminal mammary epithelial cell lineages. Furthermore, the degree of 
cellular differentiation and polarization of TDLU-like structures should be revealed by 
analysis of marker expression and assessment of cellular functionality. Finally, the interplay 
of flotation of collagen gels, i.e. matrix compliance, and medium supplements for promotion 
of TDLU-like structure formation and cellular differentiation and plasticity were supposed to 
be assessed. 
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1 Introduction 
1.1 Breast cancer 
1.1.1 Breast cancer incidence and mortality 
Breast cancer is the most commonly diagnosed cancer among women worldwide, accounting 
for approximately 1.7 million new cases in 2012. Breast cancer also represents the second 
most common cancer related death of women in more developed countries, after lung cancer 
[Ferlay et al., 2013]. In Germany, the current lifetime risk for women to develop breast cancer 
is approximately one in 8, while more than 25% of them (one in 29 women) will die from the 
disease [RKI, 2015]. Notably, survival rates have increased since the mid-90s due to 
improvements in therapy and widespread introduction of mammographic screening in the 80s, 
improving early detection of breast cancer [Althuis et al., 2005]. 
However, while 5-year relative survival rates for stage 0 or I breast cancers are almost 100%, 
those for late stage IV or metastasized cancers remain low at approximately 22% [ACS, 2014] 
and treatment options for certain types of cancer like the aggressive triple negative breast 
cancer are limited [Podo et al., 2010]. In addition, patients are frequently under- or 
overtreated due to lack of information for patient stratification [Shieh et al., 2016]. Thus, a 
better understanding of breast cancer progression and subtypes is needed in order to improve 
treatment and develop more targeted therapies.  
1.1.2 Breast cancer classification and considerations for treatment 
In the clinic, classification of breast cancer, prognostic predictions and treatment decisions are 
usually based on the clinical parameters age, node status, tumor size and histological grade 
and expression of the pathological markers estrogen receptor (ER), progesterone receptor 
(PR) and human epidermal growth factor receptor 2 (HER2/neu) [Prat et al., 2011]. This 
classification yields three main types of breast cancer: hormone receptor (HR) positive breast 
cancer (HR+, positive for ER, PR or both), HER2-amplified breast cancer and triple negative 
breast cancer (TNBC), signified by its lack of HR expression and HER2-amplification. 
Approximately two thirds of breast tumors are HR+. Patients with HR+ tumors benefit from 
treatment with hormone therapy, including treatment with Tamoxifen and aromatase 
inhibitors [ACS, 2014]. HER2+ cancers exhibit increased HER2 protein expression or contain 
extra copies of the HER2 gene. Patients with HER2 positive tumors can be treated with 
Herceptin, an antibody which binds to the HER2 receptor, thereby causing reduction in tumor 
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cell proliferation. TNBCs account for approximately 15% of invasive breast cancers, i.e. 
cancers that break through the basement membrane and invade the surrounding tissue. TNBC 
have an increased incidence in BRCA1 mutation carriers and women of African ancestry 
[Carey et al., 2006, Foulkes et al., 2010]. These tumors usually occur at a lower age and are 
more aggressive than non-TNBCs [Dent et al., 2007]. Due to lack of HR and HER2 
overexpression, chemotherapy is often the only treatment option which results in a complete 
pathological response in approximately 22% of patients and a 3-year overall survival of 94%. 
However, the remaining 80% of TNBC patients do not show a complete pathological 
response to chemotherapy, resulting in a poor 3-year overall survival of only 68% [Foulkes et 
al., 2010]. Thus, the heterogeneous response to chemotherapy of TNBCs leads to poor 
prognosis and shows the need for better characterization of this tumor type and development 
of targeted therapies.  
Within the described clinical/pathological treatment groups, there is still great biological 
heterogeneity concerning molecular alterations, cellular composition and response to therapy. 
In order to better understand biological heterogeneity and improve patient stratification, 
global gene expression analyses have been performed on human breast cancer samples. 
Thereby, five main molecular subtypes (luminal A, luminal B, HER2-enriched, basal-like and 
normal-like) have been identified [Perou et al., 2000, Sorlie et al., 2001]. In addition, another 
molecular subtype (claudin-low) has been identified more recently [Herschkowitz et al., 
2007]. Notably, tumors in the luminal A/B subgroup are characterized by high expression of 
genes like ER, KRT18, GATA3 and FOXA1 which are associated with normal mammary 
luminal cells. In contrast, expression of ER and its associated genes is low in tumors classified 
as basal-like or HER2-enriched. Instead, basal-like tumors were characterized by high 
expression of genes like KRT5, KRT17 and FZD7 which are associated with normal basal 
mammary epithelial cells [Perou et al., 2000]. The different molecular subtypes are signified 
by differences in incidence, survival and response to therapy. For instance, luminal A tumors 
present with a much better prognosis than luminal B tumors, even though clinically speaking, 
both belong to the HR+ subset of breast cancers [Prat et al., 2011, Sorlie et al., 2001].  
Classification of breast cancers is further complicated by the finding that molecular subtypes 
do not perfectly overlap with pathological markers used in the clinic. For example, up to 29% 
of basal-like tumors are ER+ and up to 13% of these tumors are HER2+. These tumors might 
therefore be classified as HR+ or HER2+ tumors in the clinic, while preliminary data suggest 
that their prognosis and response to therapy may have been better predicted by the basal-like 
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subtype [Prat et al., 2011, Sorlie et al., 2001]. Thus, there seems to be high heterogeneity even 
in the single molecular subtypes.  
In summary, limited treatment options for certain types of breast cancer, and the high 
biological heterogeneity of breast tumors together with the lack of accurate markers 
complicate patient stratification and prevent accurate prognosis and optimal treatment. 
1.1.3 The cell-of-origin and plasticity in human breast cancer 
An important consideration to better understand initiation, progression and maintenance of 
different tumor types is the identification of the cell-of-origin which is relevant for breast 
cancer characterization, development of targeted therapy and prevention efforts. The 
definitions of the molecular breast cancer subtypes luminal A/B and basal-like suggest that 
the cell-of-origin of these tumors can be found in the luminal and basal cell lineage of the 
normal human mammary gland (MG), respectively. However, this assumption has been 
challenged recently [Lim et al., 2009, Molyneux et al., 2010]. Most cancers with underlying 
BRCA1 mutation are clinically classified as TNBC and are molecularly defined as basal-like. 
However, the luminal progenitor and not the basal population was shown to be expanded in 
tumor-free breast tissue of BRCA1 mutation carriers. Cells of this expanded luminal 
progenitor population exhibited increased clonogenic activity in 3D in vitro culture and were 
relatively insensitive to the lack of growth factors, indicating aberrant growth potential [Lim 
et al., 2009]. In addition, a second study reported that targeted deletion of BRCA1 in luminal 
ER− progenitors in the mouse MG caused the formation of tumors which were pathologically 
similar to tumors found in human BRCA1 mutation carriers, while targeted deletion of 
BRCA1 in basal cells led to the generation of tumors classified as malignant 
adenomyoepitheliomas, a tumor type that rarely occurs in the human breast [Molyneux et al., 
2010].  
Together, these results strongly suggest that basal-like tumors of BRCA1 mutation carriers are 
derived from cells of the luminal progenitor rather than from the basal population. 
Furthermore, these results indicate high plasticity of mammary epithelial cell lineages which 
seems to be triggered during the process of tumor development and progression and obscure 
tumor characterization. Efforts to elucidate cellular plasticity and its involvement in 
generation of specific tumor types will play an important role for the development of 
personalized medicine for breast cancer. 
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1.2 The normal mammary gland 
Cellular plasticity and heterogeneity of breast cancer are likely a result of normal MG 
architecture and function. MG development is initiated in the embryo, but it is not until 
puberty that the MG develops into a complex network of epithelial ducts ending in clusters of 
alveoli called terminal ductal lobular units (TDLUs). During reproductive life, specifically 
every menstrual cycle, pregnancy and lactation, the MG undergoes proliferation, 
differentiation and remodeling. This enormous regenerative potential suggests the existence of 
tissue stem/progenitor cells and a high degree of cellular plasticity to ensure functional 
robustness, i.e. the production of milk. Therefore, understanding of MG architecture, 
development and differentiation processes as well as investigation of plasticity of normal 
mammary epithelial cells are the foundation to understanding breast cancer heterogeneity. 
1.2.1 Human mammary gland development and differentiation  
The MG develops after the three germ layers have formed and segmentation has taken place. 
It is made up of an epithelial compartment with ectodermal origin, embedded in a stromal 
compartment derived from the mesoderm. One of the first signs of MG development is a 
mammary ridge developing on each side of the trunk, going from groin to axilla, which has 
been reported in 15 mm human embryos. Subsequently, the mammary epithelium proliferates 
to first form a nodule and then further develops into a mammary bud, which starts pushing 
into the underlying mesenchyme. Notably, primordial cells at this stage are negative for the 
basal cell markers K14 and αSMA.  
Eventually, the mammary bud starts to invade into the underlying mesenchyme and branches, 
and the developing ducts become canalized leading to formation of the MG anlage, also called 
rudimentary ductal tree, which is present at birth (Figure 1.1). At this stage, basal cells 
become positive for K14 and αSMA [Howard et al., 2000, Russo et al., 2004]. Until puberty, 
the MG remains mainly quiescent and grows isometrically with the rest of the body as short 
ductal structures in fibroblast rich stroma.  
At puberty, sexual dimorphism occurs: while the MG in males remains quiescent, in females 
the production of reproductive hormones triggers further development (Figure 1.1). The first 
change is an increase in the amount of fibrous and fatty tissue, followed by the growth and 
division of primary and secondary ducts. Furthermore, previously blunt-ended ductal termini 
change to terminal end buds, which subsequently form new branches, twigs and small 
ductules/alveolar buds, until the MG has become a complex branched network of ducts, 
ending in collections of ductules/alveoli, the TDLUs [Howard et al., 2000, Russo et al., 2004]. 
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Rescue experiments in hormone deprived mice and rats revealed that pubertal MG 
development is mediated by five major hormones; 17-β-estradiol, progesterone and prolactin 
together with growth hormone and cortisol [Brisken et al., 2010]. Later, transplantation of 
ERα-/- and PR-/- mammary epithelial cells into cleared fat pads of wild type mice showed 
that epithelial estrogen signaling is required for ductal elongation, while epithelial 
progesterone signaling mediates subsequent side-branching and alveologenesis [Brisken et al., 
2010, Brisken et al., 1998, Mallepell et al., 2006]. In addition, engraftment of Prl-/- 
epithelium revealed that prolactin signaling is required at rather late stages of development, 
namely alveologenesis and lactogenic differentiation of mammary epithelial cells during late 
pregnancy [Brisken et al., 1999, Brisken et al., 2010, Gallego et al., 2001]. 
In the adult female, the MG undergoes cyclical changes of cell proliferation in 
synchronization with the menstrual cycle, but only fully differentiates during pregnancy and 
lactation (Figure 1.1). During pregnancy, the number of lobules increases, cells within lobules 
increase in size to prepare for secretory activity and secretory material accumulates within 
cells and in the ductules. Upon birth, the drop of placental lactogen and sex steroids, most 
importantly progesterone, trigger the onset of lactation. After weaning, the accumulation of 
milk within the ductoacinar lamina and within the cytoplasm of secretory cells inhibits the 
production of milk and induces involution. Specifically, secretory cells are removed by 
apoptosis and phagocytosis and the periductal and perilobular connective tissue is remodeled. 
Morphologically, the involuted gland of a parous woman resembles the MG of an adult virgin 
woman with more differentiated lobules [Howard et al., 2000, McManaman et al., 2003, 
Russo et al., 2004].  
Introduction 
7 
 
 
Figure 1.1 Schematic overview of postnatal human mammary gland development.  
The rudimentary mammary epithelial ductal tree present after birth starts to grow and branch during puberty, 
until it reaches the state of the adult non-pregnant gland. The mammary epithelium further grows, branches and 
fully differentiates during pregnancy and lactation. The circle indicates a developmental cycle from the mature 
non-pregnant adult gland through pregnancy, lactation and involution back to the mature non-pregnant state. 
 
1.2.2 Human mammary gland architecture 
The adult MG consists of a complex branched network of epithelial ducts. In humans, about 
10-15 lactiferous ducts arise at the nipple, invade the mammary fad pad, branch off into 
segmental ducts and terminate in clusters of alveoli, the terminal ductal lobular units (TDLUs) 
(Figure 1.1). TDLUs are the functional units of the MG and the place where milk is produced 
[Parmar et al., 2004]. Notably, most breast cancers arise within the luminal compartment of 
TDLUs [Sainsbury et al., 2000].  
The mammary ducts are composed of two main cell-types, luminal and basal epithelial cells 
(Figure 1.2). Luminal cells are located at an inner position, surrounding a central lumen, and 
secrete milk into the lumen during lactation. At the outer positions, they are surrounded by a 
single layer of contractile basal or myoepithelial cells which facilitate the transport of milk 
towards the nipple. The term basal cell was partly invented to refer to myoepithelial cells 
lining ducts, which are more cuboidal shaped than myoepithelial cells residing in alveoli 
which acquire a rather elongated/flattened morphology. However, myoepithelial cells of both 
ducts and alveoli are functionally alike, having contractile ability, high concentrations of actin 
microfilaments and staining positive for alpha smooth muscle actin (αSMA) [Howard et al., 
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2000]. Thus, the term myoepithelial or basal cell provides no functional differentiation and 
can be used interchangeably. 
Basal and luminal cells of the human MG can be distinguished by differential lineage marker 
expression. Commonly used markers for basal/myoepithelial cells include the transcription 
factors p63 and Slug, αSMA, the intermediate filament vimentin, endopeptidase CD10 and 
cytokeratin K14 [Guo et al., 2012, Lim et al., 2010, Santagata et al., 2014]. p63 serves as a 
functional marker as its expression is required for maintenance of the basal cell fate in human 
mammary epithelial cells [Yalcin-Ozuysal et al., 2010]. In addition, αSMA was shown to 
mediate the contractile function of basal/myoepithelial cells [Haaksma et al., 2011, 
Weymouth et al., 2012]. Commonly used markers for luminal cells include the transcriptional 
regulators GATA3 and Elf-5, tight junction proteins ZO-1 and claudin-4, as well as 
cytokeratin K8/18 and the glycoprotein Mucin-1 [Asselin-Labat et al., 2007, Ewald et al., 
2008, Kouros-Mehr et al., 2006, Lee et al., 2011, Oakes et al., 2008, Santagata et al., 2014, 
Stingl et al., 2001]. 
The mammary ductal epithelial network is ensheathed by a basement membrane, an 
approximately 100 nm thick sheet of extracellular matrix. The basement membrane provides a 
barrier between the epithelium and the surrounding stroma (Figure 1.2). It is composed of 
laminin polymers, crosslinked collagen IV fibrils, glycoproteins and proteoglycans like 
perlecan [Muschler et al., 2010]. Myoepithelial cells are in direct contact with the basement 
membrane by binding of their integrin-α6 receptors to laminin of the basement membrane. 
Most of the inner luminal cell population is separated from the basement membrane by 
myoepithelial cells. However, predominantly in acini, luminal cells with extended processes 
were found to contact the basement membrane in between two elongated myoepithelial cells 
[Howard et al., 2000]. In humans, mammary epithelial ducts and their associated basement 
membrane are surrounded by stroma consisting of connective tissue proteins, most abundantly 
collagen I, which lend structural support to the epithelial structure [Howard et al., 2000]. 
Stromal cells include fibroblasts and adipocytes which are interspersed with endothelial cells 
and a variety of innate and adaptive immune cells [Muschler et al., 2010, Plaks et al., 2015]. 
The various stromal cell types ensure the supply of blood and nutrients and are involved in the 
immune defense. Furthermore, they are involved in signaling events such as the proliferative 
response of mammary epithelial cells to estrogen and progesterone [Brisken et al., 2010].  
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Figure 1.2 Illustration of a cross-section of a human mammary epithelial duct surrounded by extracellular 
matrix and stromal cells. 
Luminal HMECs which secrete milk into the lumen during lactation are surrounded by a layer of contractile 
basal/myoepithelial cells which support the release of milk towards the nipple. The epithelial cells are 
surrounded by a basement membrane and are embedded in an extracellular matrix containing various cell types 
including fibroblasts, adipocytes, immune and endothelial cells.  
 
1.2.3 Differences between human and mouse mammary gland architecture, 
development and differentiation 
Detailed analysis of human MG architecture, development and cellular hierarchy is 
complicated by the low availability of tissue sections and interindividual differences. Mouse 
models do not only relieve these shortcomings, but also allow for genetic and non-genetic 
manipulations and have therefore become the major model organism for MG research. 
However, the embryonic and postnatal development of the murine MG, as well as its 
architecture and cellular composition are slightly different from the human MG [Sternlicht, 
2006].  
Like in humans, MG development in mice starts with formation of a bilateral mammary ridge 
which develops into placodes, leading to the formation of the rudimentary ductal tree present 
at birth. However, while human MG development in males and females is the same until 
puberty, androgen hormones induce condensation of the mesenchyme around the mammary 
bud in mice, resulting in its destruction already at embryonic day 14 [Sternlicht, 2006]. After 
birth, human mammary epithelial ducts range from blunt-ended tubular structures to well-
developed acinar structures, which terminate in TDLUs [Howard et al., 2000]. In contrast, 
mammary epithelial ducts of mice are blunt-ended, and it is only at puberty that terminal end 
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buds (TEBs), club shaped structures with multiple layers of inner body cells and an outer 
layer of cap cells, form and invade the fat pad. In the adult mouse, TEBs regress again and 
mammary epithelial ducts remain largely blunt-ended until the generation of alveolar buds 
during pregnancy. In the murine MG, these lobular-alveolar structures are located at the ends 
of tertiary side branches like leaves on a branch, which is in contrast to the grape-like 
architecture of TDLUs in the human MG [Sternlicht, 2006].  
Importantly, murine and human mammary epithelial ducts are embedded in a stroma which 
exhibits dramatic histological differences (Figure 1.3). In the human MG, epithelial ducts are 
closely associated with fibrous connective tissue and are separated from large areas of adipose 
tissue. In contrast, in the murine MG, the epithelium is in close contact with adipose tissue 
which is interspersed with only small amounts of connective tissue [Parmar et al., 2004].  
 
Figure 1.3 Comparison of human and mouse mammary glands.  
(A) Hematoxylin & eosin (H&E) stained section of normal human and mouse breast tissue, showing a terminal 
ductal lobular unit embedded in a fibrous connective tissue stroma (left, human) and ducts embedded in adipose 
rich stroma (right, mouse). 
(B) Schematic representation of a human TDLU (left), emphasizing the distance of the adipose tissue in contrast 
to the close association of epithelial structures with interstitial fibrous connective tissue stroma, and of the mouse 
MG (right), displaying ducts in intimate contact with fibroblasts and adipocytes. Adapted from [Parmar et al., 
2004]. 
 
Most lineage markers can be used to identify basal and luminal mammary epithelial cells of 
both human and mouse. However, there are exceptions: Mouse basal cells are usually 
identified by use of keratins K5 and K14, αSMA and Lgr5 [Mikaelian et al., 2006, Plaks et 
al., 2013], while immunohistochemical and proteomic analysis of human mammary epithelial 
cells revealed expression of K5 and K14 in both basal and luminal cells [Gusterson et al., 
2005, Santagata et al., 2014]. In addition, the expression of Lgr5 which was described as 
basal/stem cell marker of mouse mammary cells has not been assessed in human mammary 
epithelial cells yet [Plaks et al., 2013]. Importantly, the differences between human and mouse 
MG architecture, development and differentiation should be taken into account when 
comparing both systems. 
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1.2.4 Cellular hierarchy in the mammary gland 
The high regenerative potential of the MG suggests the existence of tissue stem/progenitor 
cells and cellular plasticity. Indeed, the presence of mammary stem cells (MaSCs) or bipotent 
progenitors has been suggested by a multitude of studies, most importantly transplantation 
studies. Already in 1959, de Ome et al. showed that fragments of mouse mammary tissue 
transplanted into a murine mammary fat pad cleared of endogenous epithelium could 
regenerate an entire ductal network containing both epithelial cell lineages [Deome et al., 
1959]. Subsequent transplantation studies showed that successful engraftment could be 
obtained from any tissue fragment irrespective of the temporal and spatial origin [Daniel et 
al., 1968, Hoshino, 1962, Smith et al., 1988, Young et al., 1971], indicating that a candidate 
stem cell population was located along the entire epithelial tree and persisted throughout the 
lifespan of a mouse. Moreover, it was shown that serial transplantation of mammary tissue 
fragments consistently led to regeneration of a cleared mammary fat pad at least 5-8 times 
[Daniel et al., 1971, Young et al., 1971], demonstrating the cell’s capacity to self-renew, 
which is a major hallmark of stem cells (SCs). The existence of bipotent stem/progenitor cells 
in murine MGs was further supported by formation of a functional MG mammary fat pad. 
The resulting gland contained both luminal and basal cells and showed self-renewal capacity 
in serial transplantation [Kordon et al., 1998]. These results suggested the existence of adult 
murine MaSCs/bipotent progenitors, but their identity remained elusive. However, in 2006, 
two independent research groups shed light on the identity of the regenerative cells. Using the 
cell surface markers integrin-β1 (CD29) or integrin-α6 (CD49f) in combination with heat 
stable antigen (CD24), the authors could separate luminal, basal, and stromal subpopulations 
and published a protocol for the enrichment of MaSCs/bipotent progenitors. By injecting the 
sorted luminal and basal cells into cleared mammary fat pads of recipient mice, the authors 
confirmed that single murine mammary epithelial cells were able to repopulate an entire MG. 
More importantly, they showed that the repopulating ability was contained almost exclusively 
in a CD24med/CD49fhi [Stingl et al., 2006] or CD29hi/CD24+ [Shackleton et al., 2006] 
population and therewith in the basal cell compartment. The stem cell frequency within the 
basal population was estimated to be ~1/60 to ~1/90 cells, depending on the mouse strain 
[Shackleton et al., 2006, Stingl et al., 2006]. By transplantation into humanized murine 
mammary fat pads [Kuperwasser et al., 2004] or transplantation under the kidney capsule of 
immune compromised mice [Eirew et al., 2008], it was shown that also human MECs 
contained regenerative capacity, which was found to be enriched in basal CD49f+/EpCAMneg-
low cells, suggesting that regenerative capacity is contained within the basal cell population in 
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both mouse and human (Figure 1.4A). More recently, an alternative approach for assessing 
stem cell identity and function, lineage tracing, has evolved. It allows tracking cell fate 
dynamics of stem and progenitor cells in the physiological context of development and 
homeostasis in situ. The first inducible cell fate mapping study tracked stem cell and 
progenitor activity at different stages of mammary development using fluorescent protein 
expression under tamoxifen or doxycycline inducible lineage specific keratin promoters. In 
this manner, MaSCs/ bipotent progenitors giving rise to both luminal and basal cells were 
only identified during embryogenesis, but not during puberty and homeostasis. It was shown 
that instead of MaSCs/bipotent progenitors, two types of lineage restricted progenitor cells, 
basal and luminal, contribute to the maintenance of their own lineage. This led to the 
conclusion that unipotent progenitors rather than rare MaSCs/bipotent progenitors drive 
development and homeostasis in the postnatal MG [Van Keymeulen et al., 2011]. In contrast, 
another tracing study suggested that both unipotent and bipotent progenitors contribute to 
postnatal MG development, depending on the developmental stage. Labeling and tracing of 
Wnt/β-catenin responsive Axin2+ cells revealed the presence of unipotent progenitors during 
puberty and adulthood and bipotent progenitors during pregnancy [Van Amerongen et al., 
2012]. Strikingly, both studies demonstrated that cells that were restricted to a basal fate in 
situ gave rise to both lineages upon transplantation, suggesting that transplantation assays do 
not reflect the physiological behavior of mammary stem/progenitor cells [Van Amerongen et 
al., 2012, Van Keymeulen et al., 2011].  
Further evidence for the existence of multipotent progenitors in vivo was provided by two 
recent fate-mapping studies. Using an inducible multicolor reporter under lineage specific Elf-
5 and K5 promoters, Rios et al. imaged large parts of the ductal tree and found that K5+ basal 
cells give rise to both basal and luminal cells during puberty and adulthood, thereby 
representing MaSCs/bipotent progenitors [Rios et al., 2014]. It should be noted, however, that 
a very high fraction (30%) of the mammary epithelium was labeled in this study, thereby 
confounding interpretation. In the second study, labeling and tracing of cells expressing the 
Wnt target protein C receptor (Procr) provided evidence that Procr labels a subpopulation of 
basal cells with multipotent features in vivo and high regenerative capacity in transplantation 
assays [Wang et al., 2015].  
The contradictory results concerning the existence of MaSCs/bipotent progenitor cells in vivo 
likely resulted from the use of transgenic and knock-in cre drivers for lineage tracing which 
are dynamically, temporally and heterogeneously expressed. Therefore, lineage tracing data 
are difficult to interpret. In the latest fate mapping study, this problem was approached by 
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thorough statistical analysis of multicolor lineage tracing and lineage tracing at saturation, 
again using fluorescent protein expression under inducible lineage specific K14 and K8 
promoters. Using this approach, it was statistically confirmed with a high level of certainty 
that unipotent rather than bipotent stem/progenitor cells mediate pubertal development, adult 
tissue homeostasis as well as pregnancy and lactation in the murine MG (Figure 1.4B) 
[Wuidart et al., 2016].  
 
 
Figure 1.4 Models of mammary differentiation. 
(A) Traditional model: Common bipotent progenitors maintain both luminal and basal lineages in the adult 
murine MG.  
(B) Revised model: Common bipotent progenitors only exist during embryonic MG development, while 
unipotent progenitors maintain luminal and basal lineages postnatally. Notably, bipotent progenitors can be re-
activated from postnatal basal/myoepithelial cells by transplantation. Adapted from [Keller et al., 2011]. 
 
Recently, the concept of a rare population exhibiting MaSC/bipotent progenitor features in 
transplantation assays has been challenged altogether. The authors of a paper published in 
2014 showed that approximately 50% of basal mammary epithelial cells can acquire de novo 
mammary repopulating potential when cultured in vitro in the presence of a ROCK inhibitor 
[Prater et al., 2014]. In addition, repopulating potential of murine MECs can be increased by 
culture in the presence of fibroblast-derived factors [Makarem et al., 2013]. Together, these 
observations implicate high cellular plasticity and suggest a model in which 
MaSCs/progenitors can be generated by almost any myoepithelial cell on demand. High 
lineage plasticity has also been suggested by two independent research groups who found that 
expression of constitutively active PI3K (PIK3CAH1047R) in lineage committed K5+ and 
Lgr5+ basal cells of the adult murine MG causes reprogramming into a luminal cell fate. Vice 
versa, expression in K8+ luminal cells lead to reprogramming to a basal cell fate [Koren et al., 
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2015, Van Keymeulen et al., 2015]. Considering that PIK3CAH1047R is among the most 
common mutations occurring in breast cancer [Cancer Genome Atlas Network, 2012], the 
observation that it impacts cell fate reveals a mechanism potentially underlying breast cancer 
plasticity and heterogeneity.  
Together, MaSCs/bipotent progenitors have been found in the basal cell compartment of both 
human and mouse MG by transplantation, while lineage tracing studies imply that the MG is 
maintained by unipotent progenitors after birth. However, it is not yet solved unequivocally 
whether rare MaSCs/bipotent progenitors exist in vivo and which might be the stimuli 
activating them. In addition, the fact that plasticity can be triggered by 2D culture in the 
presence of ROCK inhibitors or fibroblast-derived factors, or by overexpression of 
PIK3CAH1047R, suggests that regenerative cells can be generated de novo, which might play a 
role in tumor development/progression. More research is needed to investigate MaSC/bipotent 
progenitor features and unravel mechanisms triggering cellular plasticity and investigate their 
role in cancer development and progression. While up to date most studies are performed in 
mice, future studies should aim to confer the gained insight to the human MG. To facilitate 
the identification and characterization of human mammary stem/progenitor cells and the 
analysis of plasticity, in vitro culture models are needed in which HMECs recapitulate 
morphological and physiological characteristics of the human MG in situ. 
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1.3 The need for in vitro systems for the assessment of human MaSC 
identity and lineage plasticity  
As described above, transplantation assays and lineage tracing approaches are the most 
commonly used methods for the identification and characterization of murine MaSCs. 
However, these approaches are scarcely suited for the identification and characterization of 
human MaSCs: Lineage tracing approaches cannot be performed in human due to obvious 
ethical reasons. In addition, transplantation of primary HMECs into cleared murine mammary 
fat pads does not lead to regeneration, potentially due to differences in the mouse host stroma, 
which contains more adipose tissue than the collagen rich human stroma [Parmar et al., 2004]. 
Although the growth of HMECs in murine transplantation can be improved by introduction of 
collagen and fibroblasts, these approaches still depend on the use of organoids, small tissue 
fragments containing all mammary cell types in unknown quantities, non-human fibroblasts 
and are of very low-throughput [Eirew et al., 2008, Kuperwasser et al., 2004]. Therefore, 
human MaSC research requires in vitro assays in which HMECs recapitulate morphological 
and physiological characteristics of the human MG in situ. Unfortunately, these requirements 
are not met by currently used in vitro assays. Up to date, 2D culture on stiff polystyrene cell 
culture plates is the most commonly used culture system. In this system, cells acquire a 
flattened shape and the area and plane of cell-matrix and cell-cell contacts are different from 
in vivo. Thereby, multiple cellular processes including differentiation, migration, proliferation 
and survival are aberrantly regulated by 2D culture [Ashe et al., 2006, Tibbitt et al., 2009, 
Zhang et al., 2005]. In addition, most used culture models rely on the use of cell-lines which 
do not represent the behavior of cells in vivo, as immortalization and prolonged culture 
introduce genetic and phenotypic changes and usually lead to the selection of a subpopulation 
of cells [Birgersdotter et al., 2005, Petersen et al., 1992, Prat et al., 2013]. The biological 
relevance is also often comprised by the use of non-MG derived stromal cells. Due to the 
artificial environment the histological architecture and function of the human MG in situ is 
not recapitulated by commonly used in vitro assays [Dontu et al., 2003, Eirew et al., 2008, 
Gudjonsson et al., 2002, Stingl et al., 2005]. Therefore, new biologically relevant culture 
models are needed which allow for the identification and characterization of HMECs in vitro. 
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2 Material 
2.1 Reagents and chemicals 
Product Supplier (Catalog No.) 
1,7-Dichloro-octamethyltetrasiloxane  Santa Cruz (sc-229834) 
Aluminum potassium sulfate  Sigma (A-7167) 
A83-01 Miltenyi Biotec (130-095-565) 
Aqua-Poly/Mount  Polysciences (18606) 
β-Mercaptoethanol  Sigma (63689) 
Blebbistatin  Sigma (B0560) 
Bovine serum albumin, fraction V (BSA)  Roth (CP84.2) 
Carmine Sigma (C-1022) 
Collagen type I rat tail  Corning (354236) 
Dimethyl sulfoxide (DMSO)  Sigma (D8418) 
Forskolin  Biomol (AG-CN2_0089) 
Glycine  Roth (3790.3) 
Hanks’ Balanced Salt Solution (HBSS) Thermo Fisher Scientific (14175) 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid, 1M (HEPES) 
Life Technologies (15630) 
Growth factor reduced Matrigel  Corning (FALC354230) 
n-heptane Applichem (1948) 
Normal donor donkey serum  GeneTex (GTX73205) 
Normal donor goat serum  GeneTex (GTX73206) 
Paraformaldehyde 16% (w/v) (PFA) VWR International (043368-9M) 
Phosphate-buffered saline (PBS), pH 7.4 Life Technologies (10010056) 
Polyetyleneimine (PEI), linear Alfa Aesar (43896) 
Thiazovivin Selleckchem (S1459) 
Triton X-100 Sigma (T8787) 
Y-27632  Biomol (AG-CR1_3564) 
 
2.2 Enzymes and growth factors 
Product  Supplier (Catalog No.) 
Collagenase type I Sigma Aldrich (C0130) 
Dispase Stem Cell Technologies (07913) 
Hyaluronidase type I Sigma Aldrich (H3506) 
Insulin Sigma (I6634) 
TGF-β1 R&D Systems (240-B) 
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2.3 Cell culture media and solutions 
Product Supplier (Catalog No.) 
Dulbecco's Modified Eagle Medium (DMEM) Thermo Fisher Scientific 
Fetal calf serum (FCS), PANSera ES PAN Biotech (30-2602) 
Mammary Epithelial Cell Growth Medium (MECGM) 
including supplements: 
0.004 ml/ml Bovine Pituitary Extract 
10 ng/ml Epidermal Growth Factor (recombinant human) 
5 µg/ml Insulin (recombinant human) 
0.5 µg/ml Hydrocortisone 
PromoCell (C-21010) 
Penicillin/Streptomycin (10,000 U/ml) Invitrogen (15140122) 
Trypsin-EDTA 0.05%, 0.25% Thermo Fisher Scientific  
(25300, 25200) 
Trypsin Neutralizing Solution (TNS) PromoCell (C-41120) 
 
2.4 Composition of media, buffers and solutions 
2.4.1 Composition of media 
Media Composition 
Freezing medium for freshly isolated cells 
(FRZM1) 
50% (v/v) FCS 
40% (v/v) PCB 
10% (v/v) DMSO 
Freezing medium for cultured primary cells 
(FRZM2) 
70% (v/v) MECGM  
20% (v/v) FCS 
10% (v/v) DMSO 
Transport medium (TM)  
PCB 
5% (v/v) FCS 
Tissue digestion buffer (TDB) 
PCB 
1.5% (w/v) BSA, fraction B 
HBSS with HEPES and FCS (HF) 
HBSS 
10 mM HEPES 
2% (v/v) FCS 
Seeding medium  
MECGM 
100 U/ml Penicillin/Streptomycin  
0.5% FCS 
10 μM Forskolin 
3 μM Y-27632 
Maintenance medium  
MECGM 
100 U/ml Penicillin/Streptomycin  
10 μM Forskolin 
Basic medium 
MECGM 
100 U/ml Penicillin/Streptomycin  
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2.4.2 Composition of buffers and solutions 
Buffer/Solution Composition 
Carmine alum solution 
Distilled water 
0.2% (w/v) Carmine 
0.5% (w/v) Aluminum Potassium Sulfate 
Siloxane coating solution 
n-heptane 
25 g/l 1,7-Dichloro-
octamethyltetrasiloxane 
10+1 Neutralizing solution 
11x PBS 
550 mM HEPES 
Primary cell buffer (PCB) 
DMEM:F12 (Ratio 1:1) 
10 mM HEPES 
100 U/ml Penicillin/streptomycin 
FACS buffer 
PBS 
0.1% (w/v) BSA 
 
2.5 Kits and arrays 
Product Supplier (Catalog No.) 
Easy Script Plus cDNA Synthesis Kit Abm (G236) 
FITC BrdU Flow Kit Beckton Dickinson (559619) 
GeneChip® Human Gene 2.0 ST Array Affymetrix (902112) 
Ovation Pico WTA System V2  Nugen (3302) 
Power SYBR Green PCR Master Mix Applied Biosystems (4367659) 
QIAshredder Qiagen (79656) 
RNase-free DNase Set Qiagen (79254) 
RNeasy Mini Kit Qiagen (74104) 
UltraView Universal DAB Detection Kit Ventana (760-500) 
 
2.6 Antibodies and fluorescent stains  
2.6.1 Primary antibodies and fluorescent stains 
Epitope [Clone]  Conjugation Host Supplier (Catalog No.) Dilution 
4’,6-diamidino-2-
phenylindole (DAPI)  
- - Sigma-Aldrich (D9542) 167 
ng/ml 
CK18 [Ks18.04]  - Mouse  Progen (61028)  1:100 
E-cadherin [24E10]  Alexa 488  Rabbit  New England Biolabs (3199) 1:50 
E-cadherin [EP700Y]  - Rabbit  GeneTex (GTX61329) 1:250 
GATA3 [L50-823]  - Mouse  Biocare Medical (CM 405 C) 1:250 
Integrin-α6 [GOH3]  - Rat  Santa Cruz (sc-19622) 1:100 
K8/18 [5D3]  - Mouse  Dianova (DLN-10750) 1:100 
Laminin - Rabbit  Sigma-Aldrich (L9393) 1:100 
p63 [BC4A4]  - Mouse Abcam (ab735)  1:100 
p63 [H-137]  - Rabbit Santa Cruz (sc-8343) 1:100 
p63 [Y289] - Rabbit Abcam (ab32353) 1:100 
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Epitope [Clone]  Conjugation Host Supplier (Catalog No.) Dilution 
Phalloidin  Atto 647N - Sigma-Aldrich (65906) 1:250 
Vimentin [D21H3]  - Rabbit Biozol (5741) 1:100 
Vimentin [V9]  - Mouse Abnova (MAB3578) 1:100 
ZO-1 [1A12] Alexa 594 Mouse Thermo Fischer Scientific 
(339194) 
1:100 
ZO-1 [1A12]  - Mouse Thermo Fischer Scientific 
(339100) 
1:100 
 
2.6.2 Secondary antibodies 
Host Epitope Conjugation  Supplier (Catalog No.) Dilution 
Goat Mouse IgG Alexa 594  Life Technologies (A11032) 1:250 
Goat Rabbit IgG Alexa 488 Life Technologies (A11034) 1:250 
Goat Rat IgG Alexa 594 Life Technologies (A11007) 1:250 
Donkey Mouse IgG Alexa 488 Life Technologies (A21202) 1:250 
Donkey Rabbit IgG Alexa 546 Life Technologies (A10040) 1:250 
Donkey Rabbit IgG Alexa 594  Life Technologies (A21207) 1:250 
Donkey Rat IgG Cy3 Dianova 1:250 
Donkey Rat IgG Alexa 488 Life Technologies (A21208) 1:250 
 
2.6.3 Antibodies and fluorescent stains for flow cytometry 
Epitope [Clone] Conjugation Host Supplier (Cat. No.) Volume (µl) * 
7-Aminoactinomycin D 
(7-AAD) 
- - BD (559925) 2 
CD10 [HIC10a] APC Mouse Biozol (312210) 2.5 
CD31 [WM59] PB Mouse Biozol (303114) 0.5 
CD326/EpCAM [VU-
1D9] 
FITC Mouse Biozol (GTX79849) 5 
CD45 (HI30] V450 Mouse BD (560367) 0.5 
CD49f [GoH3] PE Rat BD (5557369 2.5 
* used to stain 1x106 cells 
 
2.7 Consumables 
Product Supplier 
6-, 24-, 48-well polystyrene cell culture plates BD 
10 cm polystyrene cell culture dishes BD 
Cell strainer (40 μm nylon) Corning 
15-, 50-ml tubes Corning 
Cyrotubes Thermo Fisher Scientific 
Filter system for sterile filtration  Sigma 
0.45 μm PVDF filter Merck Millipore 
KOVA Glasstic slide 10 with counting grids VWR International 
Microscopy slides, cut edges, matt strip Thermo Fisher Scientific 
Cover glasses, 13 mm, round VWR International 
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Product Supplier 
Micro cover glasses 22 mm x 40 mm VWR International 
Optical 384-well reaction plate Life Technologies 
Pipette tips filtered Starlab 
Pipette tips unfiltered Starlab 
Reaction tube 1.5 ml Eppendorf 
5-, 10-, 30- ml Stripettes Greiner Bio-One 
12x75 mm Tube with cell strainer cap (FACS tube)  BD Falcon  
 
2.8 Technical devices 
Product Manufacturer 
Axio Imager.M2m Zeiss 
Axioplan 2 Imaging Microscope  Zeiss 
FACSAriaTM III and IIIU BD 
FLUOVIEW FV1000 Inverted Confocal Laser Scanning 
Microscope 
Olympus 
Heracell 240i CO2-Incubator  Thermo Fisher Scientific 
Heraeus Fresco 21 Microcentrifuge Thermo Fisher Scientific 
Heraeus Megafuge 40R Centrifuge  Thermo Fisher Scientific 
Leica DM IL LED  Leica 
Mastercycler nexus gradient  Eppendorf 
Nano-Drop ND-1000  NanoDrop Technologies 
QuantStudio 12K Flex qPCR System  Life Technologies 
SteREO Lumar.V12  Zeiss 
 
2.9 Software 
Product Manufacturer 
Axiovision Rel 4.7 Zeiss 
FACS DivaTM v6.1.3 BD 
FlowJo V10 FlowJo 
FluoView FV10-ASV 1.7 Viewer Olympus 
FluoView FV10-ASW Olympus 
Gimp 2.8.2 GIM Team 
GraphPad Prism 6 GraphPad Software 
ImageJ 1.48 NIH 
MS Office  Microsoft 
Photoshop, Illustrator CS5 Adobe 
QuantStudio 12K Flex Software  Life Technologies 
ZEN 2 pro Zeiss 
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2.10 Synthetic oligonucleotides (primers) 
Target Sequence (Forward, Reverse) 
CDH1 TGCCCAGAAAATGAAAAAGG, GTGTATGTGGCAATGCGTTC 
ELF5 TAGGGAACAAGGAATTTTTCGGG, GTACACTAACCTTCGGTCAACC 
FN1 CAGTGGGAGACCTCGAGAAG, TCCCTCGGAACATCAGAAAC 
GATA3 GCCCCTCATTAAGCCCAAG, TTGTGGTGGTCTGACAGTTCG 
KRT8 TCCTCAGGCAGCTATATGAAGAG, GGTTGGCAATATCCTCGTACTGT 
RPL32 
CAGGGTTCGTAGAAGATTCAAGGG, 
CTTGGAGGAAACATTGTGAGCGATC 
MME TGGATCTTGTAAGCAGCCTCA, GCACAACGTCTCCAAGTTGC 
CDH2 ACAGTGGCCACCTACAAAGG, CCGAGATGGGGTTGATAATG 
OVOL2 ACAGGCATTCGTCCCTACAAA, CGCTGCTTATAGGCATACTGC 
TP63 AGAGAGAGGGACTTGAGTTCT, TGGTCGATGCTGTTCAGGAGC 
SNAI2 GGGGAGAAGCCTTTTTCTTG, TCCTCATGTTTGTGCAGGAG 
VIM GAGAACTTTGCCGTTGAAGC, GCTTCCTGTAGGTGGCAATC 
ZEB1 GCACAAGAAGAGCCACAAGTAG, GCAAGACAAGTTCAAGGGTTC 
TJP1 CTTACCACACTGTGCGTCCAT, AGGAGTCGGATGATTTTAGAGCA 
 
2.11 Plasmids and cell lines 
2.11.1 Plasmids  
Plasmid Description Resistance Source 
pRRL.SIN.cPPT.CMV-
GFP.WPRE 
Lentiviral expression 
vector coding for eGFP 
Ampicillin Gift from Timm 
Schröder, ETH Basel, 
Switzerland 
pMD2.G VSV-G envelope 
expressing 
Ampicillin Addgene plasmid 
12259 
psPAX2  2ng generation lentiviral 
packaging plasmid 
Ampicillin Addgene plasmid 
12260 
 
2.11.2 Cell lines 
Cell line Description Source 
HEK 293T/17 
High perfor-
mance cells 
Derivative of the 293 cell line into which the temperature 
sensitive gene for SV40 T-antigen was inserted. Highly 
trans-fectable and capable of producing high titers of 
infectious virus. 
ATCC 
(CRL-
11268) 
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2.12 Primary cells 
Donor Age (years) Parity (# Offspring) 
M1 44 1 
M2 68 1 
M3 71 2 
M4 68 2 
M6 69 1 
M7 35 2 
M8 53 2 
M9 17 0 
M10 42 1 
M12 54 0 
M16 18 0 
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3 Methods 
3.1 Cell biological methods 
All cells were maintained in sterile conditions and handled under a clean hood with laminar 
air flow. Cells were grown in an incubator at 37 °C, 95% humidity and 5% CO2. In the case of 
primary cells, oxygen levels were maintained at 3% to reduce oxidative stress. Cell lines were 
cultured at ambient oxygen of around 21%. All centrifugation steps were performed at ~490 × 
g, at 4 °C for 5 min, if not specified otherwise. 
3.1.1 Isolation of primary HMECs 
Breast tissue was obtained from healthy women undergoing reduction mammoplasty for 
aesthetic purposes at the “Nymphenburger Praxis für Plastische und Ästhetische Chirurgie” 
(Böcklinstraße 1, 80638 München). Tissue was collected in accordance with the regulations 
of the ethics committee of the Ludwig-Maximilian University, Munich, Germany (proposal 
397-12).  
Freshly obtained tissue was transported on ice and processed immediately. The mammary 
epithelial ductal tree was cleaned from adipose tissue using scalpels and then minced into 
pieces of about 1 mm3. These were enzymatically digested in tissue digestion buffer (TDB), 
supplemented with 1 μg/ml insulin, 300 U/ml collagenase, 100 U/ml hyaluronidase at 37 °C 
for approximately 16-20 h while slowly rotating (6 rpm). Next, cells were pelleted and the 
fatty supernatant was removed by aspiration after which the pellet was resuspended in 
primary cell buffer (PCB), transferred to a fresh tube and pelleted and resuspended in PCB 
again to get rid of residual fat. At this point, an optional differential centrifugation (~200 × g, 
4 °C, 3 min) allowed for enrichment of fibroblasts in the supernatant and enrichment of 
epithelial cells in the pellet. Fibroblasts in the supernatant were pelleted by centrifugation and 
cyropreserved in freezing medium (FRZM1). The pellet enriched for epithelial cells was 
dissociated in 0.15% pre-warmed trypsin-EDTA while mixing by gently pipetting for 2-3 
min. After addition of cold HBSS with HEPES and FCS (HF), cells were pelleted and further 
dissociated in 5 mg/ml pre-warmed dispase (37 °C) by gently pipetting for 1 min. Cells were 
pelleted, cryopreserved in freezing medium (FRZM1) and aliquots were stored in liquid 
nitrogen. 
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3.1.2 Thawing of primary HMECs 
Vials containing primary human mammary epithelial cells in FRZM1 were placed in a water 
bath set to 37 °C. Once thawed, cells were immediately resuspended in Epithelial Cell Growth 
Medium (MECGM) and filtered through a 40 μm strainer to remove any residual tissue 
fragments and cell aggregates. Next, cells were centrifuged and the pellet was plated in 
seeding medium. With the first medium change after 5 days, medium was changed to 
maintenance medium, unless otherwise stated. After the establishment period of 5 days, 
medium was replaced every 2-4 days. 
3.1.3 Cell counting 
For cell counting, a 10 µl aliquot of cell suspension was injected into a chamber of a KOVA 
Glasstic Slide and live cells, identified by morphology and intracellular granularity, were 
counted using a light microscope (Leica DM IL LED, 10x objective). The total number of live 
cells was calculated using the following formula:  
 
n (total # cells/sample) = mean of two squares x total volume (ml) x 104 
3.1.4 2D culture of HMECs 
Single cell suspensions containing the desired amount of fresh HMECs in establishment 
medium were seeded into polystyrene cell culture plates (12-well plate, 6-well plate or 10 cm 
dish). After an establishment period of 5 days, cells were cultured in maintenance medium. 
Once cells reached about 80-90% confluency, they were split at a ratio of 1:2 to 1:8, 
depending on the experiment and cell type. Generally, LP cells were split at a lower ratio than 
bulk, B and B+ cells. For splitting, medium was removed and cells were washed with PBS. 
Next, 0.15% trypsin-EDTA was added and cells were incubated at 37 °C until they detached, 
which usually took 2-10 min, depending on the cell type. To neutralize trypsin, three times the 
volume of trypsin neutralizing solution (TNS) was added and cells were separated 
mechanically by pipetting up and down. Optionally, 10 μl of cell suspension was taken to 
count cells before the desired amount was transferred to a 15 or 50 ml conical and 
centrifuged. The pellet was resuspended in the desired medium and seeded into a fresh 2D 
culture plate or collagen gel. 
3.1.5 3D culture of HMECs in collagen gels 
For the generation of floating collagen gels, cell culture plastics were siloxane-coated to 
facilitate detachment of gels. Briefly, polystyrene cell culture plates were incubated with 
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siloxane coating solution for 30 s at room temperature (RT) and subsequently rinsed once 
with PBS and deionized water. For attached and attached-to-floating collagen gels, uncoated 
polystyrene cell culture plates were used.  
The preparation of collagen gels was based on a published protocol [Wozniak et al., 2005] 
with modifications described below. Neutralizing solution comprising 1/10th of the volume of 
collagen solution was mixed with the desired amount of dissociated HMECs in establishment 
or maintenance medium. Next, acidified rat tail collagen type I was added and mixed with the 
cell-suspension, resulting in a final collagen concentration of 1.3 mg/ml. Quickly, 200 or 400 
μl of the gel mixture was transferred into a 48-well or 24-well cell culture plate on ice, 
respectively. The plate was placed in an incubator set to 37 °C to allow polymerization of 
collagen fibers. After 1 h, 300 (48-well plate) or 600 μl (24-well plate) of medium with 
supplements was added carefully to the edge of the culture dish. The concentration of 
supplements, including FCS, Forskolin and Y-27632 was calculated for the total volume of 
the gel with medium. To detach the collagen gels, they were encircled with a pipet tip and 
plates were gently shaken. 
Cells in collagen gels were cultured for 8 to 20 days. To determine the number of cells per 
gel, collagen gels were digested with 300 U/ml collagenase I (Sigma) for 1 h at 37 ºC, 
dissociated by treatment with 0.15% trypsin (5 min at 37 ºC), and the cell suspension was 
filtered to obtain single cells. Cells were counted as described above. 
 
Microscopy: Images of structures in collagen gels were acquired on a Leica DM IL LED 
microscope equipped with a HiPlan 10x/0.22 PH1 objective. Images of whole gels were taken 
with a Zeiss SteREO Lumar.V12 microscope with a NeoLumar S 0.8x objective (6.4 x 
Zoom). 
3.1.6 3D culture of HMECs in Matrigel  
For culture in rBM/Matrigel, the desired amount of freshly isolated and dissociated HMECs 
in establishment medium was resuspended in cold growth factor reduced Matrigel on ice and 
plated into 24-well polystyrene cell culture plates (400 μl/well). Matrigel was allowed to 
polymerize in an incubator at 37 °C. After 1 h, 600 µl of establishment medium was added 
and cultures were treated like 3D collagen gels. 
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3.2 Stainings 
3.2.1 2D immunofluorescence  
Fluorescence describes the absorption of light of a certain wavelength and subsequent 
emission of light of a longer wavelength by chemical compounds called fluorophores. 
Fluorescence microscopy makes use of this phenomenon to reveal the presence of molecules 
of interest with high sensitivity and spatial resolution. For this, fluorescently labeled 
antibodies are used, which recognize primary antigen-specific antibodies. The secondary 
antibodies can be detected using a regular wide field epifluorescence microscope to irradiate 
the specimen with excitation light and visualize the resulting emission light [Abramowitz et 
al., 2012, Herman et al., 2012]. 
 
For the preparation of samples for 2D immunofluorescence, all steps were performed at RT, 
unless stated otherwise. Tables containing all primary and secondary antibodies with their 
respective dilutions are presented in Chapter 2.6.1 and 2.6.2, respectively. 
 
Cells were grown on poly-D-lysine-coated glass coverslips. Once cells had reached the 
desired confluency, medium was removed and cells were washed once in PBS, fixed with 4% 
paraformaldehyde for 15 min, and washed three times with PBS. Next, cells were 
permeabilized with 0.2% Triton X-100 for 2 min, washed once with PBS and were then 
blocked with 10% goat or donkey serum in 0.1% BSA for 1-2 h. After another washing step 
with PBS, the coverslips were placed on 50 μl of primary antibody solution in 0.1% BSA. 
After an incubation period of 1-2 h, the coverslips were washed by dipping them 5 times into 
PBS, and were then placed on 50 μl of secondary antibody solution in 0.1% BSA. After an 
incubation period of 2-3 h, the coverslips were washed by dipping them 5 times into PBS, and 
were then laid on 50 μl of 167 ng/ml DAPI staining solution for about 4 min. Next, coverslips 
were washed extensively by 10 times dipping into PBS, followed by 5 times dipping into MQ. 
Excess water was removed by dabbing the edges of the coverslip with a paper towel. 
Coverslips were mounted using a drop of Aqua-Poly/Mount mounting medium and allowed to 
dry over night at RT. 
Images were acquired on an Axioplan 2, or on an Axio Imager.M2m imaging microscope 
using a 20x objective. Images were processed with Axiovision Rel 4.7/ Zen 2 pro and Gimp 
2.8.2/Adobe Photoshop CS5 software. 
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3.2.2 3D immunofluorescence  
In regular wide-field epifluorescence microscopy as used for 2D immunofluorescence 
described above, the entire specimen is illuminated and out-of-focus fluorescence often 
results in decreased resolution in the focal plane, which is a particular problem of thick 
specimens. Thus, for imaging of the thick structures generated in floating and attached 
collagen gels, confocal microscopy was used, which makes use of pinholes to focus excitation 
light and prevent detection of out-of-focus emission light. Thus, by only allowing detection of 
light from close to the focal plane, confocal images have better resolution than regular wide-
field images, especially in the sample depth direction [Fellers et al., 2012].  
 
For the preparation of samples for 3D immunofluorescence, all steps were performed at room 
temperature on an orbital shaker, if not indicated otherwise. Tables containing all primary and 
secondary antibodies with their respective dilutions are presented in Chapter 2.6.1 and 2.6.2, 
respectively. 
 
Collagen gels were washed with PBS for 10 min, fixed with 4% paraformaldehyde for 15 min 
and washed again with PBS for 10 min. Remaining paraformaldehyde was quenched by 
addition of 0.15 M glycine for 10 min, upon which gels were washed again with PBS for 10 
min. Cells were permeabilized with 0.2% Triton X-100 for 10 min and washed with PBS for 
10 min, followed by blocking with 10% goat or donkey serum in 0.1 % BSA for 2-3 h at RT 
or overnight at 4 °C. After another washing step with PBS for 10 min, primary antibodies in 
0.1% BSA were added and incubated at 4 °C overnight. After two washing steps with PBS for 
10 min each, 167 ng/ml DAPI was added for 4 min to stain nuclei. Next, gels were washed 
with PBS three times for 10 min each and twice with deionized water for 5 minutes each. 
Collagen gels were transferred to a microscopy slide and excess water was removed using a 
dust-free tissue. Gels were mounted by adding 2-3 drops of Aqua-Poly/Mount mounting 
medium and then slowly placing a microscopy coverslip on top of the gels, without 
introducing any bubbles. Mounted gels were allowed to dry at RT overnight or at 4 °C over 
the weekend. 
 
Images were acquired on a FLUOVIEW FV1000 inverted confocal laser scanning microscope 
equipped with four laser lines (405, 488, 543, and 633 nm) and UPLSAPO 60x, 40x and 20x 
objective lenses. FV-10-ASW 1.7 Viewer and Gimp 2.8.2/Adobe Photoshop CS5 software 
were used to adjust brightness across the entire image field. 
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3.2.3 Carmine staining 
The carmine dye, a complex of aluminum and the natural dye cochineal, is commonly used to 
stain wholemounts of mouse MGs in order to reveal the ductal epithelial structure of the gland 
[Dapson, 2007]. Therefore, in this study, carmine staining was used to visualize the structures 
growing in collagen gels.  
 
Carmine staining solution was prepared by boiling 1 g carmine and 2.5 g aluminum potassium 
sulfate in 500 ml distilled water for 20 min. After boiling, the final volume of the solution was 
adjusted to 500 ml by adding distilled water and the solution was strained through a filter 
system for sterile filtration. A crystal of thymol was added for preservation and the staining 
solution was stored at 4 °C. For staining of collagen gels, the gels were fixed as described 
above and incubated in carmine staining solution overnight at RT on an orbital shaker. 
Collagen gels were transferred to microscopy slides, excess water was removed with a dust-
free tissue and gels were mounted as described above. 
 
Images of single structures were acquired on a Leica DM IL LED microscope with a HiPlan 
10x/0.22 PH1 objective and whole mount pictures were taken with a Zeiss SteREO 
Lumar.V12 microscope with a NeoLumar S 0.8x objective (10-20x zoom). 
3.2.4 Immunohistochemistry and hematoxylin and eosin staining 
Immunohistochemistry and hematoxylin and eosin (H&E) stainings were kindly provided by 
Harald S. Bartsch and Karl Sotlar (Institute of Pathology, Medical School, Ludwig 
Maximilian University Munich, Munich 80337, Germany). 
 
For immunohistochemistry, collagen gels were fixed in 4% paraformaldehyde as described 
above and embedded in paraffin. 2 μm thick sections were cut from the paraffin block and 
stained with primary antibodies listed in Chapter 2.6.1. Primary antibodies were detected by 
species specific HRP-linked secondary antibodies (ultraView Universal DAB Detection Kit) 
according to the manufacturer’s protocol. 
 
For hematoxylin and eosin staining, formalin-fixed and paraffin-embedded (FFPE) breast 
tissues from cosmetic breast reduction surgeries from the tissue archives of the Institute of 
Pathology, Ludwig-Maximilians-University Munich, Munich, Germany, were cut into 2 μm 
thick sections and stained with H&E according to standard protocols. H&E stained sections 
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were examined by two pathologists to exclude samples exhibiting signs of dysplasia or 
malignancy. Tissue samples were anonymized in accordance with the ethics committee 
regulations.  
3.2.5 Morphological analysis of gels, structures and cells  
To quantify the amount of branching points, the longest branch was determined for each 
structure. From there, primary, secondary, tertiary and quaternary side branches were counted. 
One branching point was counted for each side branch.  
To determine the area size of gels, structures and cells, images were opened in Image J and, if 
needed, spatially calibrated against an image with known value. Subsequently, the area size 
was determined using the tool for measurement of areas. Structures were counted using the 
ImageJ cell counter. Structures containing at least two branching points were considered 
branched.  
3.3 Flow Cytometry 
Flow cytometry allows for the analysis and sorting of single cells and was used in this study 
to derive subpopulations of HMECs. For analysis by flow cytometry, a single cell suspension 
is usually stained with fluorescently labeled antibodies and then aspirated into the FACS 
machine, where the cells pass multiple laser beams allowing for the determination of relative 
cell size, complexity/granularity and expression of cellular markers (labeled protein). For 
sorting, droplets containing one cell each are generated, charged with a certain electrical load 
after which they get separated by two installed deflection plates. The deflected droplets can 
then be collected.  
3.3.1 Surface staining  
For fluorescent staining of cells, freshly isolated HMECs were thawed, taken up in MECGM, 
given through a 40 μm strainer to remove any residual tissue fragments and cell aggregates 
and then counted. After centrifugation, cells were resuspended in FACS buffer and stained 
with fluorescent antibodies CD31-PB,CD45-V450, CD49f-PE, EpCAM-FITC and CD10-
APC (antibodies are listed in Chapter 2.6.3) for 40 min on ice protected from light. After 
washing with PBS, controls were resuspended in approximately 500 μl FACS buffer per 
1x106 cells and samples were resuspended in 100 μl FACS buffer per 1x106 cells to allow for 
efficient sorting. 7-AAD was added to one control and all samples, and incubated for at least 
15 min to exclude dead cells from the analysis. 
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3.3.2 Analysis and sorting of cells 
For analysis and sorting of primary HMEC populations, cell debris was excluded based on 
SSC-A/FSC-W followed by exclusion of doublets using both FSC-A/FSC-W and SSC-
A/SSC-W gates. Live (7-AAD−), Lineage negative (Lin−, CD31−, CD45−) cells were then 
separated into four populations based on the expression of CD49f and EpCAM. (Stroma: 
CD49f−/EpCAM+, LM: CD49f−/EpCAM+, LP: CD49f+/EpCAM+, B: CD49fhi/EpCAM−). The 
basal (B) population was further subdivided into B− and B+ cells (B−: 
CD10−/CD49fhi/EpCAM−, B+: CD10+/CD49fhi/EpCAM−) using a FACSAriaTM III/IIIU. 
Desired populations were sorted into tubes containing basic medium, using the purity or 4-
way purity mode to ensure that only drops free of contaminating cells were sorted. After the 
sort, cells were washed losing as few cells as possible, by directly adding PBS to the limit of 
the tube. Tubes were then centrifuged and the pellet was taken up in seeding medium (2D 
culture) or in basic medium (3D culture). The leftover cells were reanalyzed by flow 
cytometry to assess purity of the sort. Only experiments with less than 1% of contaminating 
cells were used for experiments and further analysis. FlowJo V10 was used for post-analysis. 
3.4 Extreme limiting dilution analysis 
In limiting dilution analysis, cells are usually seeded/transplanted in degrading dilutions up to 
doses in which no activity can be detected any more. By counting the cultures/transplants in 
which activity can be detected, the rate of cells of interest can be inferred [Hu et al., 2009].  
In order to determine structure-forming units (SFU), HMECs were seeded into floating 
collagen gels in limiting dilution up to doses in which no branched structure/sphere formation 
could be detected. At least six gels per cell dose were prepared in 48-well plates, as described 
in Chapter 4.1.5. The generated structures were stained with carmine and images were taken 
on a Zeiss SteREO Lumar V12 microscope with a NeoLumar S 0.8× objective (10-20× 
zoom). Gels which contained at least one branched structure were counted as positive. 
Branched structures were defined as containing at least two branching points and being 0.057 
mm2 or more in size. Limiting dilutions were analyzed using ELDA software, a webtool 
described previously [Hu et al., 2009]. This webtool is especially suited for analysis of 
limiting dilution data from stem cell research, as it implements methods to give reliable 
confidence intervals in situations when all assays give positive or negative results and 
includes a test to compare active cell frequencies between multiple data sets [Hu et al., 2009]. 
Using this method, 95% confidence intervals for the frequency of active cells in a group and 
p-values to compare differences in active cell frequencies between groups, are given.  
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3.5 Molecular biology techniques 
3.5.1 RNA extraction 
For RNA extraction, the RNeasy Mini Kit in combination with QIAshredder columns and the 
RNase-free DNase Set from Qiagen were used. In case of 2D cultures, cells were grown on 6-
well polystyrene plates to approximately 80% confluency. Plates were placed on ice and each 
well was washed with PBS and lysed with 350 µl RLT buffer containing 1% β-
mercaptoethanol to prevent degradation of RNA by RNases. In case of freshly isolated cells, 
cells were sorted by FACS as described above and collected in MECGM. After centrifugation 
at ~490 × g for 5 min, medium was removed and the pellet was lysed in RLT buffer 
containing 1% β-mercaptoethanol. For homogenization, cell lysates were vortexed for 30 s, 
frozen at -80 °C for at least 1 h, thawed on ice and again vortexed for 30 s. Cell lysates were 
transferred to QIAshredder columns and centrifuged for 2 min at maximum speed (21100 × g) 
for further homogenization and removal of cellular debris. RNA was purified using the 
RNeasy Mini Kit from Qiagen (silica technology), including an additional DNA-digestion 
step using the RNase-free DNase Set from Qiagen, both of which were performed according 
to the manufacturer’s instructions. RNA was eluted in RNAse free water and stored at -80 °C. 
3.5.2 Determination of RNA concentration 
RNA concentration was measured photometrically using the Nano-Drop ND-1000. 
Specifically, absorption of light at a wavelength of 260 nm was measured against a water 
reference, and RNA concentration was determined by the software based on Beer’s Law. 
3.5.3 Reverse transcription 
1 μg total RNA was reverse transcribed using the EasyScriptPlus cDNA Synthesis Kit from 
Applied Biological Materials, according to the manufacturer’s Oligo(dT) protocol. 
Synthesized cDNA was stored at -20 °C. 
3.5.4 Quantitative real time polymerase chain reaction (RT-PCR) 
Quantitative real-time PCR (RT-PCR) was performed using the PowerSYBR® Green PCR 
Master Mix from Applied Biosystems. The reaction mixture per sample had a volume of 10 
μl, containing 2 μl (10 ng) cDNA, 0.25 μl (50 nM) of each forward and reverse primer, 2.5 μl 
DNase/RNase-free H2O and 5 μl PowerSYBR Green PCR Master Mix containing 
deoxynucleotides (dNTPs), SYBR® Green I Dye and AmpliTaq Gold® DNA Polymerase 
(Table 3.1). Samples were run on a QuantStudio 12K Flex qPCR System with the cycling 
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program listed in Table 3.2. Briefly, AmpliTaq Gold® DNA Polymerase was activated and 
double-stranded cDNA was detected during 40 cycles of amplification. After amplification, a 
melting curve was generated to assess the dissociation-characteristics of the generated cDNA 
dimers during heating, allowing for detection of nonspecific product formation.  
Relative expression of the target gene compared to the housekeeping gene PRL32 was 
calculated according to the ΔCT method (Schmittgen and Livak, 2008) by subtracting the CT 
value of the gene of interest from the CT value of the housekeeping gene. The fold change of 
transcript levels between gene of interest and housekeeping gene was determined with the 
formula 2ΔCT. We chose to show absolute values of a representative single experiment 
multiplied by 1000. All primers used are listed in Chapter 2.10. 
 
Table 3.1 RT-PCR reaction mixture per sample 
Component Used Volume (Final concentration) 
Forward primer 0.25 μl (50 nM) 
Reverse primer 0.25 μl (50 nM) 
DNase/RNase-free H20 2.5 μl 
PowerSYBR Green PCR Master Mix 5 μl 
cDNA 2 μl (1 ng/μl) 
Total volume 10 μl 
 
 
Table 3.2 RT-PCR cycling program 
Cycles Step Temperature Duration 
1 
Initial activation of AmpliTaq Gold® DNA 
Polymerase 
95 °C 10 min 
40 
Denaturation to yield single stranded cDNA 
molecules 
95 °C 15 s 
Annealing of primers to cDNA 60 °C 30 s 
Extension of cDNA 72 °C 16 s 
 Melting curve 70 to 95 °C  
 
3.5.5 Microarray 
For gene expression analysis, the Affymetrix Human Gene 2.0 ST array, a single-channel 
whole transcriptome DNA-microarray, was used. This array contains short unlabeled DNA 
molecules (probes) of a known sequence. The target cDNA specifically binds to probes with 
complementary DNA sequence after which probe-target pairs can be detected and quantified. 
3.5.5.1 Expression profiling 
For expression profiling, total RNA from freshly sorted HMECs (B−, B+ and LP populations) 
was isolated using the RNeasy Mini Kit, in combination with QIAshredder columns and 
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RNase-free DNase Set (all Qiagen), as described above. Further processing of RNA samples, 
expression profiling and statistical transcriptome analysis were kindly performed by Martin 
Irmler (Institute of Experimental Genetics, Helmholtz Center Munich, Neuherberg, 
Germany). 
In short, total RNA was amplified and reverse transcribed using the Ovation Pico WTA 
System V2 according to the manufacturer’s protocol. This system is optimized to generate 
cDNA from small amounts of RNA for use in gene expression analysis applications including 
microarrays. Generation of the first strand of cDNA is achieved using a mix of RNA/DNA 
chimeric oligodT and random primers and reverse transcriptase. Thereby, amplification is 
initiated both at the 3’end as well as throughout the entire transcriptome of the sample, such 
that even compromised RNA is reverse transcribed. The resulting mRNA/cDNA hybrid 
molecules contain a RNA tag sequence (SPIA tag) at the 5’end of the cDNA molecule. In the 
second step, the mRNA is fragmented allowing DNA polymerase to synthesize a second 
cDNA strand, containing DNA complementary to the RNA SPIA tag. Amplification of cDNA 
is achieved using the chimeric DNA/RNA SPIA primers, DNA polymerase and RNase H.  
After removal of the RNA portion of the SPIA primer by RNase H, a new SPIA primer can 
bind and DNA polymerase starts to synthesize cDNA, thereby displacing the existing strand. 
Importantly, every time a SPIA primer binds to the cDNA, a new substrate for RNase H is 
created, triggering the next round of cDNA synthesis. Thus, by constant initiation of DNA 
replication, this method allows for rapid accumulation of cDNA even from low amounts of 
RNA.  
 
Encore Biotin Module from Nugen was used for chemical and enzymatic fragmentation and 
biotin-labeling of amplified cDNA. The resulting 50-100 base long cDNA products were 
subsequently hybridized on Affymetrix Human Gene 2.0 ST arrays. Washing, staining and 
scanning were done according to the Affymetrix Expression Protocol including minor 
modifications as suggested in the Encore Biotin Protocol. 
3.5.5.2 Statistical transcriptome analysis 
Expression console (v.1.3.0.187, Affymetrix) was used for quality control and to obtain 
annotated normalized RMA gene-level data (standard settings including median polish and 
sketch-quantile normalisation). 
Statistical analyses were performed by utilizing the statistical programming environment R 
[R.D.C.T., 2008] implemented in CARMAweb [Rainer et al., 2006]. Genewise testing for 
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differential expression was done employing the (limma) t-test and Benjamini-Hochberg 
multiple testing correction (FDR <10%). To reduce the background, sets of regulated genes 
were filtered for average expression >10 in at least one of the three groups. Heatmaps were 
generated with CARMAweb.  
Gene Ontology (GO) term enrichment is based on the Gene Ontology system of classification 
of sets of genes. In this classification system, genes are assigned to predefined bins based on 
their functional characteristics. GO term and pathway enrichment analyses (p<0.01) were 
done with GePS (Genomatix). This system makes use of information from public and 
proprietary databases to identify enriched pathways and GO terms. 
 
Array data have been submitted to GEO (Accession Number GSE64248): 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=cvwdayyudbydzwj&acc=GSE64248 
 
3.5.5.3 Principal component analysis  
Principal component analysis (PCA) was used to reduce the dimensionality of data with the 
intention to find patterns in a multidimensional microarray dataset. PCA is a mathematical 
algorithm which allows for reduction of the dimensionality of data while maintaining most of 
its variation. For this, principal components are identified as new variables. The first principal 
component is determined as the direction at which the samples have the largest variation. 
Next, the direction which is uncorrelated (perpendicular) to the first principal component and 
along which the samples again show the largest variation is determined. This direction 
represents the second principal component [Ringner, 2008]. Thereby, each sample was 
represented by only two variables (principal components) and was plotted in a two 
dimensional scatter plot. Principal component analysis was kindly performed by Steffen Sass 
(Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany).  
3.5.6 Lentivirus production and transduction of target cells 
Lentiviral vectors are a valuable tool for the delivery of transgenes into the genome of target 
cells. Their ability to integrate into the genome of both dividing and non-dividing cells is an 
advantage over other retroviruses, which only integrate into the genome of dividing cells. In 
this study, second generation vectors were used to produce replication defective, self-
inactivating lentiviruses which are safe to work with.  
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3.5.6.1 Plasmids and virus production  
Production of Lentivirus expressing eGFP or mCherry was kindly performed by Benjamin 
Hirschi (Institute of Stem Cell Research, Helmholtz Center for Health and Environmental 
Research Munich, Neuherberg, Germany). In short, 6 μg pRRL vector coding either for eGPF 
or mCherry, 2.1 μg pMD2.G envelop plasmid, and 3.9 μg psPAX2 packaging plasmid were 
mixed with 36 µl polyethyleneimin (PEI) transfection reagent followed by incubation for 15 
min. The transfection mix was added dropwise to HEK293T high performance cells cultured 
at 70-80% confluency on a 10 cm cell culture dish in DMEM + 10% FCS. After incubation at 
37 °C overnight, medium was removed and changed to 5 ml MECGM basic medium. Cells 
were kept at 37 °C and virus containing medium was collected 24 h and 48 h post 
transfection, filtered through a 0.45 μm PVDF filter to remove cell debris, and stored at 
-80 °C. 
3.5.6.2 Lentiviral transduction of target cells 
HMECs from donors M8, M9, M10 were thawed as described above and cultured in a 6-well 
polystyrene cell culture plate in 2 ml establishment/maintenance medium. At day 7 of culture, 
half of the medium was replaced by fresh maintenance medium before 1 ml of lentiviral 
GFP/Cherry suspension containing 3.3 μg/ml protamine sulfate, was slowly added to the cells. 
Addition of positively charged polycations like protamine sulfate enhances transduction 
efficiency of lentiviral vectors by reducing repulsion between negatively-charged cells and 
virus and mediating binding of the viral particle to the cell surface [Denning et al., 2013].  
After incubation for 4 h at 37 °C, medium containing the viral particles was removed, cells 
were washed twice with PBS and then trypsinized with 0.3 ml 0.15 % trypsin to destroy all 
remaining virus and generate a single cell suspension. After all cells had detached, trypsin 
was neutralized by addition of 1 ml TNS, cells were filtered through a 35 μm nylon mesh and 
counted as described above. Next, cells exposed to lentiviruses carrying eGFP or mCherry 
were mixed in a 1:1 ratio and seeded into floating collagen gels at different densities (100, 
500, 2000, 5000 cells per 400 μl gel) in maintenance medium. Gels containing 500-5000 and 
gels containing 100 cells were fixed after 17 and 18 days, respectively, and were subsequently 
stained with DAPI and mounted as described above. 
3.6 Statistical analysis 
Box-and-whisker plots to present data as median ± 25% were generated with GraphPad Prism 
Software using the Tukey method for plotting whiskers and outliers. All other data are 
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presented as mean ± standard deviation (SD). Student’s t-test was used to compare two groups 
(two-tailed, unpaired), unless stated otherwise. *p<0.05 was considered significant.  
A correlation coefficient (r) was calculated to measure the direction and strength of a possible 
linear relationship between two variables. In correlation analysis, r is always between –1 and 
+1: r = –1 describes a perfect negative linear relationship, r = 0 indicates that there is no 
linear relationship and r = +1 describes a perfect positive linear relationship. Thus, the closer 
r is to  
–1/+1, the stronger the linear relationship. Here, I describe a correlation of r ≥ 0.7 / ≤ –0.7 as 
strong, ≥ 0.5 / ≤ –0.5 as moderate and ≥ 0.3 / ≤ –0.3 as weak [Taylor, 1990]. 
The correlation coefficient was determined using the “CORREL” function of Excel.  
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4 Results 
4.1 Development of a three-dimensional culture system for the generation 
of breast organoids 
4.1.1 Primary HMECs generate TDLU-like structures in floating collagen gels 
The major aim of this study has been the development of an organotypic 3D culture model for 
primary HMECs, in which morphological and physiological characteristics of the human MG 
in situ are recapitulated (see ‘Aims of the study’). Collagen I is the major component of the 
human breast ECM and provides defined properties that can be modified in vitro to change 
physical parameters or to model different microenvironments by addition of ECM 
components. Furthermore, it has previously been shown that primary human mammary 
organoids form branched structures when cultured within collagen I gels and that cells of the 
human breast carcinoma cell line T47D can build tubules in floating collagen I gels, implying 
the ability to self-organize in the described environment [Foster et al., 1983, Wozniak et al., 
2005].  
Therefore, I chose to use collagen I (hereafter referred to as collagen) as substrate for a 3D 
culture system. I seeded single primary HMECs into floating collagen gels based on the 
previously published protocol by Wozniak and Keely, to determine whether this would allow 
generation of multicellular structures that recapitulate the complex architecture of the MG in 
situ [Wozniak et al., 2005]. To do so, a single cell suspension of freshly isolated HMECs was 
mixed with neutralizing solution and acidic collagen type I on ice, and subsequently 
transferred to a siloxane coated cell culture dish. After polymerization, collagen gels were 
detached by encircling them with a pipet tip followed by careful shaking of the plate 
(Figure 4.1A).  
After 10-12 days, I observed the formation of a variety of multicellular structures that could 
be divided into non-branched and branched structures (Figure 4.1B). The non-branched 
structures included tubule-like structures (sticks), and round structures (spheres and multi-
spheres). The branched structures all contained multiple branching points, resembling the 
complex branched network of human breast epithelium. Two types of branched structures, 
named thin and star-like structures, had very thin ducts. In addition, the latter was 
characterized by a high number of ducts emerging from the center of structures, thereby 
failing to recapitulate the branched morphology of the epithelium of the human MG in situ. In 
contrast, the third type of branched structure showed complex branching with thick ducts and 
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distinct alveoli at the end of the ducts. These structures resembled TDLUs, the functional 
units of the human MG in situ and the place where most breast cancers arise (Figure 4.1C). 
Therefore, these structures were called TDLU-like structures.  
 
 
Figure 4.1 Generation of TDLU-like structures in floating collagen gels. 
(A) Generation of floating collagen gels. In short, a single cell suspension of HMECs in culture medium was 
mixed with neutralizing solution on ice. Next, collagen I was quickly added and the mixture was transferred into 
siloxane coated cell culture plates. Collagen was allowed to polymerize for 1 h at 37 °C, after which cell culture 
medium was added carefully to the edge of the dish. Next, collagen gels were detached by encircling the gels 
with a pipet tip and careful shaking of the plate. 
(B) Bright-field microscopy: carmine-stained representative images of different types of branched and non-
branched structures in floating collagen gels (donor M8). Scale bar: 200 μm. 
(C) Bright-field microscopy: Hematoxylin and Eosin-stained section of a TDLU from a healthy woman. Scale 
bar: 100 μm. 
 
 
4.1.2 Matrigel does not support the generation of TDLU-like structures 
Another hydrogel which is commonly used for 3D culture of MECs is rBM/Matrigel (see 
Chapter 1.3). To compare cellular behavior in Matrigel with that in floating collagen gels, 
freshly isolated HMECs were seeded in pure Matrigel or in a mixture of 50% collagen and 
50% Matrigel. Strikingly, growth of HMECs was not supported under these conditions (data 
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not shown), suggesting that Matrigel does not represent a physiological extracellular 
environment for HMECs. In line with these observations, it has been reported that HMECs 
need to be established in 2D conditions before they can be cultured in Matrigel or, 
alternatively, require the presence of stromal cells [Dontu et al., 2003, Eirew et al., 2008]. 
Taken together, as culture in floating collagen better supported the growth of HMECs and 
allowed for the formation of structures resembling TDLUs of the human MG in situ, I chose 
to use collagen as substrate for a 3D culture system. 
4.1.3 Improvement of culture conditions to promote the generation of TDLU-like 
structures  
Seeding HMECs into floating collagen gels and quantifying the different types of structures 
revealed that only about 1/2,000 cells was able to give rise to a branched structure and even 
fewer cells, 1/10,000, gave rise to a TDLU-like structure. To promote the growth of cells 
giving rise to TDLU-like structures, thereby facilitating their characterization, I sought to 
improve culture conditions. Rho-associated kinase (ROCK) is a downstream effector of the 
small GTPase RhoA, an important regulator of the cytoskeleton and cellular contraction. 
Upon activation by RhoA, ROCK phosphorylates and activates LIM kinase, leading to 
inactivation of the actin-depolymerizing factor cofilin and stabilization of actin filaments. In 
addition, activated ROCK promotes cellular contractility by phosphorylation of myosin light 
chain (MLC) and inactivation of MLC phosphatase [Amano et al., 2010]. Inhibitors of ROCK 
were promising candidates to improve culture conditions for TDLU-like structure forming 
cells, as they were shown to increase colony formation of murine MECs in both 2D and 3D 
culture systems [Guo et al., 2012, Makarem et al., 2013]. In addition, it was recently shown 
that inhibition of ROCK can increase the regenerative potential of mouse MECs which are 
cultured in 2D and then transplanted back into a cleared fat pad [Prater et al., 2014].  
Therefore, two different inhibitors of ROCK, Y-27632 and Thiazovivin, were added to the 
growth medium upon plating of freshly dissociated HMECs. Strikingly, treatment with 3 μM 
of Y-27632 increased branched-structure formation by 5-fold (Figure 4.2A) and formation of 
TDLU-like structures by 3-fold (Figure 4.2B). Similarly, treatment with Thiazovivin 
increased branched structure formation up to 7-fold (Figure 4.2A). Notably, higher 
concentrations of ROCK inhibitors, i.e. 10 μM Y-27632 or 1 μM Thiazovivin prevented 
formation of TDLU-like structures and instead promoted formation of star-like structures 
(Figure 4.2C). In addition, morphogenesis was completely perturbed if treatment with ROCK 
inhibitors was continued after 5 days of culture (Figure 4.2E). However, the fact that 
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prolonged treatment/high concentrations of ROCK inhibitor perturbed morphogenesis is not 
surprising considering that ROCK signaling regulates actin cytoskeleton dynamics and 
cellular contraction. Thus, a single initial treatment with 3 µm Y-27632 at initial plating, and 
subsequent removal of ROCK inhibitors by a complete medium change at day 5 of culture, 
was implemented into the standard 3D culture protocol in order to promote cell survival and 
structure formation as well as proper morphogenesis. Importantly, the addition of ROCK 
inhibitors primarily promoted the formation of branched structures which had thin ducts and 
few alveoli and were classified as thin and star-like structures (Figure 4.2C).  
Compounds like Forskolin and Cholera Toxin cause an increase of intracellular levels of the 
second messenger cAMP by activation of adenylate cyclase. They are commonly used for 
culture of mammary epithelial cells and have been described to promote polarization and 
lumen formation in 3D cultures of the epithelial breast cell line MCF10A [Nedvetsky et al., 
2012, Stampfer, 1982]. Thus, I added Forskolin to the cell culture medium to promote 
alveologenesis of branched structures. Indeed, when adding 10 μM Forskolin to freshly 
isolated primary HMECs in floating collagen gels, I observed a 3-fold increase in the 
formation of branched structures (Figure 4.2A) and a 12-fold increase in the formation of 
TDLU-like structures (Figure 4.2B), while the formation of non-branched structures was 
increased by only 1.5-fold (Figure 4.2D). Importantly, Forskolin promoted the formation of 
TDLU-like structures also in the presence of 1-10 μM Y-27632 or 0.1-0.3 μM Thiazovivin 
(Figure 4.2B), so that both ROCK inhibitors and Forskolin could be used together to 
specifically increase the number of TDLU-like structures formed. However, in the presence of 
high concentrations (1 μM) of Thiazovivin, the ability of Forskolin to promote formation of 
TDLU-like structures seemed to be lost, likely due to Thiazovivin overriding the effect of 
Forskolin (Figure 4.2B).  
In summary, treatment with 3 μM Y-27632 once at initial plating of cells and subsequent 
removal at day 5 of culture, together with continuous treatment with 10 μM Forskolin with 
every medium change, optimally promoted the formation of TDLU-like structures and was 
therefore used as standard culture condition. 
Results 
41 
 
 
Figure 4.2 Identification of culture conditions promoting the generation of TDLU-like structures. 
(A) Freshly isolated HMECs (donor M8) were cultured in the presence of different concentrations of Forskolin 
(continuous treatment), Y-27632 and Thiazovivin (both one-time treatment at day 0 of culture) in floating 
collagen gels for 14 days. 400 μl collagen gels, 1x104 cells seeded per gel. n=3 gels/condition. Structure 
formation is given per 100 seeded cells. 
(B) Effect of different culture conditions on the generation of TDLU-like structures, refer to (A). n=3 
gels/condition. Structure formation is given per 100 seeded cells. 
(C) Effect of different culture conditions on the ratio of thin, star and TDLU-like branched structure subtypes, 
refer to (A). n=3 gels/condition.  
(D) Effect of culture conditions on the generation of non-branched structures, refer to (A). n=3 gels/condition. 
Structure formation is given per 100 seeded cells.  
(E) Bright-field microscopy: representative images of basal cells (donor M5) in floating collagen gels, treated 
with 10 μM Y-27632 one-time at day 0 of culture or treated with every medium change. Scale bar: 200 μm.  
(A,B,D) Data are shown as mean ± standard deviation (s.d.).  
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4.1.4 TDLU-like structures can be passaged 
A hallmark of murine MaSCs/progenitors is self-renewal which can be assessed by serial 
transplantation into and repopulation of cleared mammary fat pads. Analogous to this, I tested 
whether HMECs were able to generate TDLU-like structures over multiple passages in 
floating collagen gels. Thus, I seeded single cell suspensions of HMECs into floating collagen 
gels. Once structures had formed, the collagen gels were enzymatically digested and the cells 
were trypsinized and filtered. The resulting single cell suspension was then re-plated into 
floating collagen gels. I observed that HMECs could generate branched structures for up to 2 
passages (Figure 4.3A). At passage 3, branched structure formation was replaced by sphere 
formation indicating loss of regenerative, but maintenance of proliferative capacity. Based on 
these results, the culture system developed here can be used to analyze the self-renewal 
capacity of HMECs for up to two passages. To allow for TDLU-like structure formation for 
more than 3 passages, future studies should aim to further improve 3D culture conditions.  
4.1.5 TDLU-like structure formation is maintained in 2D culture in the presence of 
Forskolin 
Genetic manipulation and expansive growth are facilitated in 2D rather than 3D culture 
conditions. Thus, I tested whether TDLU-like structure forming cells can be maintained in 2D 
culture conditions. For this, freshly isolated bulk HMECs were cultured in 2D on regular 
polysterene culture plates for five passages.  
For quantification of cells with TDLU-like structure forming ability, extreme limiting dilution 
analysis (ELDA) was performed [Hu et al., 2009]. For this method, limiting dilutions of 2D-
cultured HMECs were seeded into floating collagen gels for passage 1, 3 and 5 (Figure 4.3B).  
Once structures had formed, gels containing at least one TDLU-like structure were quantified. 
The ELDA-software tool was used to calculate the rate of TDLU-like structure forming cells 
in the different conditions. ELDA revealed a branched structure forming unit (B-SFU), 
describing the fraction of cells able to give rise to a TDLU-like structure, of 1/290 and 1/250 
for cells of passage 1 and 3, respectively. Notably, B-SFU of passage 5 cells was dramatically 
decreased to 1/1350 cells, indicating loss of regenerative capacity over multiple passages 
(Figure 4.3A). The fact that regenerative capacity was maintained longer in 2D- than in 3D-
cultured HMECs suggests that a stiff rather than a compliant culture environment supports an 
undifferentiated cell state.  
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Figure 4.3 Forskolin is required for maintenance of TDLU-like structure formation in vitro. 
(A) Bright-field microscopy: representative images of HMEC-derived branched structures (donor M8), at 
subsequent passages in 3D. Scale bar: 200 μm.  
(B) Experimental setup: freshly isolated HMECs (donor M4) were cultured in 2D in the absence or presence of 
10 μM Forskolin for five passages, and transferred to floating collagen I gels in limiting dilution at passage 1, 3 
and 5. p=passage.  
(C) Extreme limiting dilution analysis: determination of branched structure-forming units (B-SFU) at passage 1, 
3 and 5 after 2D culture, refer to (B). Data are mean and 95% confidence intervals (CI). 
(D) Confocal microscopy: representative TDLU-like structures at passage 1, 3, and 5 after 2D culture, refer to 
(B). Vimentin (red), E-cadherin (green), integrin-α6 (red), DAPI (blue). Scale bars: 100 μm. 
 
Importantly, maintenance of regenerative capacity required the presence of Forskolin, as cells 
cultured in its absence had completely lost regenerative ability already at passage 1 
(Figure 4.3C). Notably, this loss of regenerative ability coincided with epithelial to 
mesenchymal transition (EMT), i.e. the loss of epithelial and the acquisition of mesenchymal 
features.  
The process of EMT is involved in critical steps of morphogenesis, fibrosis and cancer 
progression [Lamouille et al., 2014, Thiery et al., 2009]. Epithelial cells are characterized by 
apico-basal polarity and strong cell-cell adhesion. In 2D culture settings, epithelial cells 
Results 
44 
 
exhibit a cobblestone-like morphology and are usually contained within well-organized 
clusters. Markers for epithelial cells include cell-cell adhesion molecule E-cadherin and 
membrane-localized β-catenin, which links cadherins to the cytoskeleton [Lamouille et al., 
2014, Thiery et al., 2009]. Another marker of epithelial cells is the zinc finger transcription 
factor Ovol2 (Ovo-like 2) which was shown to protect the epithelial cell fate of murine MECs 
required for normal mammary morphogenesis and regeneration in vivo [Watanabe et al., 
2014]. 
During EMT, epithelial cell-cell adhesion is lost, cells acquire migratory and invasive features 
and exhibit front-to-back polarity. In mesenchymal cells, E-cadherin is typically replaced by 
N-cadherin, and the cells express intermediate filament vimentin and fibronectin, a 
glycoprotein of the ECM. Additional markers for EMT include Twist, Snail, Slug and Zeb1 
which are pleiotropically acting transcription factors mediating the EMT program 
downstream of extracellular signals [Lamouille et al., 2014, Thiery et al., 2009]. Snail and 
Slug belong to the Snail family of zinc finger transcription factors. They can promote EMT by 
binding to E-box motifs found in the E-cadherin promoter region, repressing transcriptional 
expression of E-cadherin [Batlle et al., 2000, Cano et al., 2000]. ZEB1 is another zinc finger 
TF and can also repress E-cadherin transcriptional expression by binding to E-box motifs in 
its promoter region [Eger et al., 2005]. However, all of these transcription factors not only 
affect transcription of E-cadherin but have been implicated in transcriptional downregulation 
of other cell-cell adhesion proteins such as claudins, occludins and desmosome proteins as 
well as the transcriptional upregulation of mesenchymal markers like fibronectin and N-
cadherin [Lamouille et al., 2014, Thiery et al., 2009].  
Immunofluorescence revealed that passage 1 cells cultured in floating collagen gels in the 
absence of Forskolin generated loose agglomerations of round cells. These agglomerations of 
cells were positive for the mesenchymal marker vimentin while retaining expression of E-
cadherin (Figure 4.3D, left). When cells cultured in the absence of Forskolin were transferred 
to floating collagen gels at later passages, they showed complete front-to-back polarization 
and had lost all expression of E-cadherin, indicating acquisition of a mesenchymal phenotype 
(Figure 4.3D, right).  
The acquisition of a mesenchymal phenotype was also reflected in 2D cultures. Cells cultured 
in 2D in the absence of Forskolin acquired front-to-back polarization and downregulated 
epithelial markers E-cadherin and membranous β-catenin, while they upregulated 
mesenchymal markers fibronectin and Zeb1 as determined by immunofluorescent staining 
(Figure 4.4A). The acquisition of mesenchymal features was further reflected at the transcript 
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level by downregulation of epithelial marker OVOL2 and upregulation of mesenchymal 
markers ZEB1, CDH2 (encoding N-cadherin), VIM, and FN1 (Figure 4.4B).  
Thus, the switch from epithelial to mesenchymal phenotype was reflected by changed 
transcriptional and post-transcriptional expression of multiple markers. Interestingly, within 5 
passages in the absence of Forskolin, CD49f/integrin-α6 was lost on both protein and 
transcript level (Figure 4.4C). As CD49f is the major receptor for the basement membrane 
component laminin, these findings suggest that the interaction of cells with their environment 
becomes defective in the absence of Forskolin which likely affects the cell’s inability to 
generate branched structures in floating collagen gels. Together, these results suggest that 
culture of HMECs in the presence of Forskolin prevents 2D culture induced EMT and 
maintains regenerative potential.  
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Figure 4.4 Forskolin prevents 2D culture induced EMT. 
(A) 2D-Immunofluorescence: representative images of HMECs cultured in 2D, in the absence or presence of 10 
μM Forskolin at passage 1, 3 and 5 (donor M4). Integrin-α6 (red), vimentin (green), β-catenin (red), E-cadherin 
(green), fibronectin (red), Zeb1 (green), DAPI (blue). Scale bar: 100 μm.  
(B) RT-PCR: ZEB1, CDH2 (N-cadherin), VIM (vimentin), FN1 (fibronectin) and CDH1 (E-cadherin), ITGA6 
(integrin-α6), OVOL2, ELF5 and GATA3 mRNA expression of HMECs cultured in 2D, as described in (A). n=3. 
Data are shown as mean ± standard deviation (s.d.). 
(C) Flow cytometry analysis of CD49f and EpCAM expression in Lin- HMECs cultured in 2D (see Figure 4.3B).  
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4.1.6 Single HMECs give rise to TDLU-like structures 
MaSCs/bipotent progenitors of the mouse MG are defined by the ability of a single cell to 
regenerate a cleared mammary fat pad in serial transplantation [Shackleton et al., 2006, Stingl 
et al., 2006]. Thus, if single HMECs are able to form a TDLU-like structure in floating 
collagen gels, the assay can be used as proxy for reconstitution of a cleared mammary fat pad. 
To read out the ability of single HMECs to generate a TDLU-like structure, I tested clonality 
of TDLU-like structures.  
To test whether single HMECs can give rise to a TDLU-like structure, a fraction of HMECs 
was labeled with eGFP or mCherry fluorescent protein by lentiviral transduction. A mixture 
of eGFP-, mCherry-expressing and unlabeled cells was then seeded into floating collagen gels 
in increasing concentrations of 100, 500, 2000 and 5000 cells/gel. Once TDLU-like structures 
had formed after 10-11 days, gels were fixed with paraformaldehyde and nuclei were stained 
with DAPI. Confocal microscopy was used to determine the frequency of clonal structures 
identified by complete overlap of eGFP or mCherry with DAPI. By contrast, polyclonal 
structures were multicolored. Quantification of monoclonal and polyclonal structures showed 
that gels seeded with 100 to 500 cells contained mainly monoclonal structures with a 
complete overlap of eGFP/mCherry and DAPI and only few multicolored structures (Figure 
4.5A,B). Of the multicolored structures, some consisted of two large monoclonal parts and 
apparently had merged late in their developmental process. Others contained intermingled 
patches of colored cells and therefore likely had merged at the beginning of structure 
formation. Importantly, the fraction of multicolored structures increased with high cell 
densities (Figure 4.5A; 2000 to 5000 cells/gel), suggesting that polyclonality is largely a result 
of proximity. Interestingly, the ratio of spheres to branched structures increased in gels seeded 
with higher numbers of cells, suggesting that high density impairs branched-structure 
formation (Figure 4.5C). Indeed, it has been previously reported that regeneration and 
bipotent capacity of murine MECs are reduced if cells are transplanted in the presence of 
luminal cells [Van Keymeulen et al., 2011]. In summary, these results show that single 
HMECs are able to give rise to TDLU-like structures if seeded at low density. Thereby, 
TDLU-like structure formation in floating collagen gels can be used as proxy assay for MG 
reconstitution.  
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Figure 4.5 Single HMECs give rise to TDLU-like structures. 
(A) Quantification of monoclonal, merged and polyclonal structures formed by eGFP, mCherry and unlabeled 
passage 1 cells (donors M8, M9, M10) in floating collagen I gels: 100, 500, 2000 or 5000 cells were seeded per 
well (24-well plate). Monoclonal: complete structure eGFP or mCherry positive. Merged: monoclonal structure 
merged with second structure. Polyclonal: eGFP/mCherry-positive and -negative areas. n≥9 eGFP/mCherry-
positive structures/condition.  
(B) Confocal microscopy: representative images of monoclonal, merged and polyclonal structures as defined in 
(A). Scale bar: 100 μm. 
(C) Quantification of the ratio of spheres and branched structures in floating collagen gels used for analysis of 
clonality in (A). n=5 fields of view of at least 6 gels/condition. Data are shown as mean ± standard deviation 
(s.d.).  
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4.2 Enrichment of TDLU-like structure forming cells 
4.2.1 TDLU-like structure formation varies between donors 
The composition and behavior of HMECs depend on the genetic background, hormonal status 
and developmental stage of the individual donor from which they are derived [Tanos et al., 
2012]. HMECs used in this study were obtained from a variety of donors, ranging between 
17-69 years of age and parity of 0-2. Therefore, the cells were expected to exhibit 
heterogeneous TDLU-like structure forming ability in floating collagen gels. To assess 
reproducibility of TDLU-like structure formation between donors, bulk HMECs from 9 
different donors were seeded into floating collagen gels. Branched structure formation, i.e. the 
number of branched structures formed per seeded cells, was very heterogeneous as was 
expected from the different ages and parity of the donors (Figure 4.6A-C). Based on the 
results, donors could be divided into three groups defined by high, medium and low branched 
structure formation. Specifically, donors M7/M3/M4 exhibited high, donors M10/M8/M9 
medium and donors M2/M6/M1 low branched structure formation with an average of 0.23, 
0.11 and 0.04% of cells giving rise to a branched structure, respectively. Sphere formation, 
i.e. the number of spheres generated per seeded cells, was also very heterogeneous between 
different donors. Notably, sphere formation did not reflect branched structure formation, as 
donors with low branched structure formation presented with high or low sphere formation 
and vice versa (Figure 4.6B,C).  
As HMECs from donor M8 presented with moderate branched structure and sphere forming 
ability, they were used to determine a representative value for both parameters. For this, M8 
HMECs were seeded into floating collagen gels in limiting dilution for ELDA which revealed 
a B-SFU of 1/1005 and sphere-structure forming unit (S-SFU) of 1/55 (Figure 4.6D). In 
summary, HMECs from different donors exhibit differences in TDLU-like structure and 
sphere formation which may be determined by multiple parameters, including genetic 
background, hormonal status and developmental stage. Notably, age- and parity-dependent 
differences in structure formation could not be detected within cells from the limited number 
of donors analyzed. However, the influence of the different parameters on branched structure 
and sphere formation will need to be assessed in more detail in future studies using a larger 
patient group.  
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Figure 4.6 The frequency of TDLU-like structure-forming cells varies between donors. 
(A) Bright-field microscopy: carmine-stained representative images of TDLU-like structures from freshly 
isolated bulk HMECs of nine donors (M1-M4, M6-M10) in floating collagen I gels. 400 μl collagen gels, 2x104 
cells seeded per gel. Scale bar: 200 μm. 
(B) Branched-structure formation/100 seeded HMECs at day 9 of culture. n=2 gels/donor.  
(C) Sphere formation/100 seeded HMECs at day 9 of culture. n=2 gels/donor. 
(D) Extreme limiting dilution analysis: determination of sphere and branched structure-forming units (S-SFU 
and B-SFU, donor M8). Data are mean and 95% confidence intervals (CI). 
(B,C) Data are shown as mean±s.d 
 
4.2.2 TDLU-like structure formation is increased by short-term 2D culture 
Genetic manipulation is facilitated by 2D rather than 3D culture, as both DNA and viruses are 
more easily taken up in 2D or spin transductions than in 3D cultures. However, 2D culture 
does not recapitulate the mechanical environment, morphology and function of the tissue in 
vivo and may thereby affect stem cell/progenitor function. In Chapter 4.1.5 it was shown that 
TDLU-like structure formation is maintained in 2D culture for up to two passages. Next, I 
wanted to test whether the differences in branched structure formation between different 
donors (Figure 4.6A-C) was also maintained upon 2D culture. For this, HMECs used in 
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Figure 4.6B,C had also been established in 2D culture. For passage 2, these HMECs were 
transferred into floating collagen gels (Figure 4.7A). The morphologies of TDLU-like 
structures generated by freshly isolated and 2D-cultured HMECs were similar, suggesting that 
cell-behavior was not significantly changed upon short-term establishment in 2D culture 
(Figure 4.6A, 4.7A). However, the differences in branched structure formation observed at 
passage 0 were not reflected after 2D culture (Figure 4.6B, 4.7B). Specifically, at passage 0, 
HMECs from donors M7/M3/M4 exhibited the highest branched structure forming capacity. 
In contrast, after 2D culture (passage 2), the highest branched structure forming ability was 
observed in HMECs from donors M10/M8/M9. These data suggest that differences in 
branched structure formation are not maintained in 2D culture. In addition, branched structure 
forming cells from different donors seem to have different abilities to expand/ be generated in 
2D culture.  
Notably, short-term 2D culture generally increased branched-structure and sphere formation 
efficiency by ~12-fold and ~4-fold, respectively (Figure 4.7B,C). This dramatic increase 
might be explained by the observation that at least 50% of freshly isolated HMECs are not 
viable, as determined by labeling with 7-AAD (Figure 4.7D). 7-AAD is a cell-death marker 
which labels dying cells by penetrating the cell membrane and intercalating with DNA, 
thereby changing its fluorescent properties. The low viability determined by 7-AAD staining 
likely resulted from the process of tissue dissociation, digestion and further processing (which 
takes up to 28 hours) and subsequent cryostorage. Thus, a high fraction of freshly isolated 
cells seeded into floating collagen gels does not survive, resulting in underestimation of 
structure forming potential. However, once established in 2D culture, a higher percentage of 
cells survive passage into floating collagen gels, which is then reflected in increased structure 
formation.  
In summary, the ratio of branched structure forming cells is more than doubled upon short-
term 2D culture. These data suggest that in 2D culture, branched structure forming cells either 
expand more efficiently than other HMECs, or that HMECs acquire branched structure 
forming ability de novo. However, the original differences in branched structure formation 
between donors were not reflected after 2D culture, suggesting that branched structure 
forming cells from different donors have different abilities to expand/ be generated in 2D 
culture.  
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Figure 4.7 The frequency of TDLU-like structure-forming cells is increased by 2D culture.  
(A) Bright-field microscopy: carmine-stained representative images of TDLU-like structures from nine donors 
(M1-4, M6-M10), 12 days of 2D culture prior to transfer to collagen I gels. 400 μl collagen gels, 8x102 cells 
seeded per gel. Scale bar: 200 μm.  
(B) Branched-structure formation/100 seeded HMECs, established in 2D culture (see E) at day 9 of culture. n=2 
gels/donor. 
(C) Sphere formation/100 seeded HMECs, established in 2D culture (see E) at day 9 of culture. n=2 gels/donor.  
(D) Viability of freshly isolated HMECs determined by FACS, using 7-AAD: n=10 donors (M1-M10).  
(B,C,D) Data are shown as mean±s.d 
 
4.2.3 CD10+/CD49fhi/EpCAM− cells are enriched for TDLU-like structure formation 
Reconstitution of cleared mammary fat pads in vivo has suggested that murine 
MaSCs/bipotent progenitors are enriched within the basal cell population [Shackleton et al., 
2006, Stingl et al., 2006]. Studies using human mammary epithelial cells have concluded that 
also human MaSCs are enriched within the basal population [Eirew et al., 2008]. Thus, I set 
out to determine whether TDLU-like structure forming cells were predominantly contained 
within the basal cell population. Specifically, I determined whether the size of the basal and 
luminal cell population predicts TDLU-like structure and sphere formation in floating 
collagen gels. For this purpose, I used a previously established FACS protocol to purify basal 
and luminal cell populations [Eirew et al., 2008]: 7-AAD was used to exclude dead cells. To 
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exclude endothelial and hematopoietic cells, the markers CD31 and CD45 were used. CD31, 
also known as platelet endothelial cell adhesion molecule (PECAM)-1, is an adhesion 
molecule belonging to the immunoglobulin superfamily. It is expressed on the surface of 
endothelial cells, platelets, monocytes, polymorphonuclear cells and some circulating 
lymphocytes, predominantly naïve CD8+ T-cells [DeLisser et al., 1994]. CD45, also known 
as Protein tyrosine phosphatase, receptor type, C (PTPR), is a phosphatase which is involved 
in the cellular response to environmental processes. It is expressed on all nucleated 
hematopoietic cells except erythrocytes and plasma cells. CD45 is also expressed on 
hematopoietic stem cells and osteoclasts which are of hematopoietic origin [Hermiston et al., 
2003, Shivtiel et al., 2008].  
By sorting for 7-AAD−/CD31−/CD45− cells, the mammary cell suspension was thus cleared of 
the majority of dead, endothelial and hematopoietic cells. In the next step, viable (7-AAD−) 
Lin− (CD31−/CD45−) cells were subdivided based on expression of CD49f and EpCAM. This 
yielded 4 populations: stromal cells (Stroma, CD49f−/EpCAM−), luminal mature cells (LM, 
CD49f−/EpCAM+), luminal progenitor cells (LP, CD49f+/EpCAM+), and basal cells (B, 
CD49fhi/EpCAM−) (Figure 4.8A). Stroma and LM cells did not show clonogenic activity in 
floating collagen gels and were therefore excluded from analysis (data not shown). For 
analysis, freshly isolated bulk HMECs from nine different donors were seeded into floating 
collagen gels and allowed to generate structures. Next, the number of sphere and TDLU-like 
structures formed per seeded cells was correlated with the size of the LP and basal population 
among viable Lin− cells from flow cytometry analysis (Figure 4.8B,C). Specifically, 
correlation analysis was performed as described in Chapter 3.6. Linear correlations with a 
correlation coefficient (r) of r = ≥0.7/≤–0.7, r = ≥0.5/≤–0.5 and r = ≥0.3/≤–0.3 were described 
as strong, moderate and weak, respectively. Cells of the basal population showed weak 
negative correlation with sphere formation (r = −0.22) as well as weak positive correlation 
with branched structure formation (r = 0.14). These data suggest that the basal population is 
depleted of sphere forming cells and likely contains rare branched structure forming cells. In 
contrast, the size of the LP population showed strong positive correlation with sphere 
formation (r = 0.80) and moderate negative correlation with branched structure formation (r = 
−0.68), suggesting that LP predominantly form spheres. 
As discussed above, regenerative potential was ascribed to the basal population in both human 
and mouse. In addition, correlation analysis performed here suggested that the LP population 
predominantly forms spheres. Therefore, the lack of correlation between basal population size 
and regenerative potential was likely due to heterogeneity of the basal population. 
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Thus, I reasoned that additional cell surface markers may allow for enrichment of cells with 
TDLU-like structure forming ability within the basal population. A thorough literature search 
revealed the cell surface metalloendopeptidase CD10 as possible candidate to enrich for 
TDLU-like structure forming cells. CD10 antibody was reported to label the myoepithelium 
in immunohistochemical sections of normal human breast tissue [Santagata et al., 2014]. 
Furthermore, CD10 had previously been used as marker for basal HMECs 
[Bachelard‐Cascales et al., 2010, Keller et al., 2012]. In addition, CD10 was shown to enrich 
for HMECs with the ability for form mammospheres, i.e. proliferate in anchorage 
independence, a trait associated with MaSCs [Bachelard‐Cascales et al., 2010]. Thus, I 
analyzed the expression of CD10 in HMECs from nine donors by FACS. This analysis 
revealed two distinct populations within the CD49fhi/EpCAM− basal (B) cell fraction with on 
average ~30% of basal cells expressing CD10. CD10 was also expressed on average in 10%, 
1% and 47% of the LM, LP and stromal fraction, respectively (Figure 4.8D).  
Strikingly, branched structure formation moderately correlated with the size of the CD10+ 
basal population (r = 0.44). In contrast branched structure formation only weakly correlated 
with the size of CD10+ fractions of stroma, LP or LM cells (Figure 4.8E; r = −0.2, 0.15, 0.08, 
respectively). These data suggested that CD10 expression within the basal population can be 
used to enrich for cells with regenerative capacity.  
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Figure 4.8 TDLU-like structure-forming potential correlates with the size of the CD10+/CD49fhi/EpCAM− 
population.  
(A) FACS strategy for freshly isolated HMECs: dead cells (7-AAD− = live), hematopoietic (CD45+) and 
endothelial cells (CD31+) were excluded. EpCAM and CD49f were used to depict the following populations 
among live (7-AAD−) Lin− (CD45−/CD31−) cells: stroma (CD49f−/EpCAM−), luminal mature (LM, 
CD49f−/EpCAM+), luminal progenitors (LP, CD49f+/EpCAM+) and basal (B, CD49fhi/EpCAM−). LP and basal 
(B) populations were isolated. The basal (B) population was further subdivided into B− 
(CD10−/CD49fhi/EpCAM−) and B+ (CD10+/CD49fhi/EpCAM−) cells.  
(B) Linear correlation between sphere formation/100 freshly isolated HMECs and size of the LP population 
(blue dots), or size of the B population (red dots) within the Lin− population. One dot represents one donor.  
(C) Linear correlation between TDLU-like structure formation/100 freshly isolated HMECs and size of the LP 
population (blue dots) or the basal (B) population (red dots) within the Lin− population. One dot represents one 
donor. 
(D) Percentage of CD10+ cells within the 4 populations defined by CD49f and EpCAM described in (A) based 
on flow cytometry. The average of 10 donors is shown (M1-M10). Data are shown as mean ± standard deviation 
(s.d.).  
 (E) Linear correlation between branched structure formation and size of the CD10+ stromal population 
(CD10+/CD49f−/EpCAM−), the CD10+ LP population (CD10+/CD49f+/EpCAM+,), the CD10+ LM population 
(CD10+/CD49f−/EpCAM+) and the CD10+ basal (B) population (CD10+/CD49fhi/EpCAM−, red dots). One dot 
represents one donor.  
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To test for this, I sorted basal cells, CD10+ basal cells (named B+), CD10− basal cells (named 
B−) and LP cells and seeded them into floating collagen gels in limiting dilution to quantify 
branched structure forming units (B-SFU).  
ELDA revealed that approximately one in 413 B+ cells gave rise to a TDLU-like structure 
(B-SFU = 1/413). Thereby, the B+ population was dramatically enriched for B-SFU over all 
other populations, with 7-, 30- and 12-fold enrichment over the basal (basal all), B− and LP 
cells, respectively (Figure 4.9A). Within the basal CD49fhi/EpCAM− population, the vast 
majority of TDLU-like structure forming cells is thus contained within the B+ population 
while the B− population is almost devoid of these cells (B-SFU = 1/12386). Therefore, CD10 
is a useful marker to enrich for TDLU-like structure forming cells within the basal 
CD49fhi/EpCAM− population of the human MG. Based on some published sorting protocols 
CD10 can be utilized instead of CD49f to enrich for basal cells [Bachelard‐Cascales et al., 
2010, Keller et al., 2012]. However, the results presented here reveal that CD10 must be used 
in combination with CD49f and EpCAM in order to deplete CD10 positive cells of luminal 
and stromal populations which are generally lacking regenerative potential. 
 
 
Figure 4.9 TDLU-like structure-forming potential is contained within a CD10+/CD49fhi/EpCAM− 
population 
(A) Extreme limiting dilution analysis: Determination of branched structure-forming units (B-SFU) of B+ (Basal 
+), B− (Basal−), basal (Basal all) and LP populations defined in (A) from donors M8, M9 and M10. Data are 
mean and 95% confidence intervals (CI). 
 
Notably, the B-SFU determined for the B+ population is likely an underestimation of their 
true TDLU-like structure forming ability as FACS is toxic in 50-75% of cells [Giraddi et al., 
2015]. Furthermore, the cells still need to adjust to the in vitro environment as they are 
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cultured for the first time and unknown quantities of cells are lost during handling. Therefore, 
the B-SFU of 1/413 cells observed in the B+ population suggests that TDLU-like structure 
forming cells are not rare.  
Strikingly, also the LP population displayed limited TDLU-like structure formation (B-SFU = 
1/5122, see Chapter 4.2.6 and 4.5.1). There are different possible explanations for this 
observation. First, the LP population might have been contaminated with basal cells during 
the sorting procedure. Second, the LP population might indeed contain rare luminal cells 
which have the ability to generate TDLU-like structures. Third, TDLU-like structure forming 
ability might have been induced by de-differentiation of LP cells after isolation from the MG. 
The possible scenarios will be discussed in detail in Chapter 4.2.6. 
In summary, I have found that TDLU-like structure forming cells are predominantly 
contained within the basal cell population. Within this population, CD10 can be used to 
further enrich for cells with TDLU-like structure forming ability, revealing that these cells 
cannot be considered rare. 
4.2.4 CD10+/CD49fhi/EpCAM− cells belong to the basal lineage 
ELDA revealed that B+ cells are enriched for TDLU-like structure forming cells compared to 
B− and LP cells. To analyze the unique features of B+ cells over B− and LP cells, gene 
expression profiling was performed on freshly sorted B+, B− and LP cells from six donors. 
Genewise testing for differential expression was done employing the (limma) t-test and 
Benjamini-Hochberg multiple testing correction (FDR <10%). To reduce the background, sets 
of regulated genes were filtered for average expression >10 in at least one of the three groups. 
To compare overall gene expression patterns of the different samples, principal component 
analysis (PCA) was used. PCA is a mathematical algorithm which allows for reduction of the 
dimensionality of data while maintaining most of its variation (see Chapter 3.4.4.3). By the 
identification of two new variables (principal components), each sample could be represented 
in a two dimensional scatter plot (Figure 4.10A). Notably, PCA revealed a clearly distinct 
cluster for each population, irrespective of the donor. Thus, gene expression patterns are 
robust within the sorted subpopulations even though the size of the distinct subpopulations 
varies. In addition, these results reflect the robustness in structure formation within these 
populations (Figure 4.10A): Cells of the LP and B+ population predominantly form spheres 
and TDLU-like structures, respectively. Most cells of the B− population do not build 
multicellular structures. Based on the current literature, it was assumed that both the B+ and 
B− population belong to a population exclusively containing basal cells [Eirew et al., 2008]. 
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Strikingly, however, there was a great distance between the B+ and the B− cluster on the axis 
of both principal components, indicating that B+ and B− cells have a very distinct gene 
expression pattern (Figure 4.10A). Considering that the majority of B− cells does not 
proliferate/form multicellular structures in vitro, these data put into question the basal 
epithelial identity of these cells.  
 
Figure 4.10 The CD10+/CD49fhi/EpCAM− population expresses basal markers 
(A) Gene expression profiling: mRNA for microarray analysis was derived from the three subpopulations B+, 
B− and LP from freshly isolated HMECs of six donors (M3, M6, M8, M9, M10, M12). Unsupervised clustering 
of all samples was followed by principal component analysis (PCA).  
(B) Heatmap: expression values of up- and downregulated luminal and basal genes in all samples. Fold-change 
of B+ versus LP expression levels. Red (high) and blue (low) indicates log2 expression values. Scale bar is in 
log2.  
(C) RT-PCR: Expression of MME/CD10, TP63, SNAI2, GATA3, ELF5 and KRT8 mRNA in B+ and LP cells. 
n=3. Data are shown as mean ± standard deviation (s.d.).  
 
To assess the lineage identity of the different subpopulations, I compared the transcript levels 
of genes (FDR <10%; average expression >10) characteristic for basal or luminal cell fates 
(Figure 4.10B). As expected, the basal-associated gene MME, coding for CD10, was most 
highly expressed in B+ cells, validating the sorting procedure. Other basal-associated genes 
like TP63 and SNAI2 were also upregulated in B+ cells [Guo et al., 2012, Lim et al., 2010, 
Santagata et al., 2014]. In contrast, luminal-associated genes like GATA3, ELF5 and KRT8 
were more highly expressed in LP cells than in B+ cells (Figure 4.10B) [Asselin-Labat et al., 
2007, Kouros-Mehr et al., 2006, Lee et al., 2011, Oakes et al., 2008, Santagata et al., 2014]. 
The expression level of these genes was confirmed by qPCR (Figure 4.10C).  
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As expected, these results confirmed that the LP and B+ populations contain cells with a 
luminal and basal gene expression pattern, respectively. Use of the marker combination 
CD10+/CD49fhi/EpCAM− and CD49f+/EpCAM+ thus seemed to enrich for basal and luminal 
HMECs, respectively. In contrast, the expression of both basal and luminal-associated genes 
was low in B− cells (Figure 4.10B,C). Use of the marker combination 
CD10−/CD49fhi/EpCAM− thus seems to enrich for cells with neither basal nor luminal 
mammary epithelial gene expression pattern. Thereby, these results put into question the 
epithelial identity of B− cells.  
4.2.5 CD10−/CD49fhi/EpCAM− cells might represent a specialized mammary stromal 
population 
As the B− population did not seem to belong to the basal or luminal lineage based on gene 
expression profiling (Figure 4.10B), a more unbiased approach was chosen to reveal the 
identity of cells within this population. Analysis of the 20 most highly upregulated transcripts 
(FDR<10%; average expression >10) in the B− over B+ population included IGK (encoding 
immunoglobulin chains), LYVE1 and CDH5 (encoding VE-cadherin), indicative of B cells, T 
cells, as well as lymph and vascular endothelial cells (Figure 4.11A). To obtain a functional 
profile of the genes expressed by B− cells, GO-term analysis was performed on genes 
differentially regulated between B− and B+ population with a FDR<10%, average expression 
>10 and FC>3×. GO-term analysis revealed groups of genes associated with circulatory 
system development, cytokine-receptor binding, antigen binding, VEGF and angiogenesis to 
be significantly overrepresented in the B− compared with the B+ gene expression profile 
(Figure 4.11B). Together, these data suggest that the B− cell population predominantly 
comprises stromal cells, specifically vascular- and lymphendothelial cells as well as B and T 
cell lymphocytes. Notably, I expected these cells to be removed during the sorting procedure 
by exclusion of CD31 and CD45 positive cells. In line with a stromal identity of B− cells, it 
has been argued that all cells located at basal positions express CD10 in 
immunohistochemical sections of the human MG [Santagata et al., 2014]. Notably, these 
results indicate that depletion of stromal cells using CD31 and CD45 as markers for exclusion 
of endothelial and hematopoietic cells does not result in their complete elimination. In line 
with this, it has been reported that certain types of endothelial cells, for instance those found 
in spleen and kidney capillaries, are negative for CD31 [Pusztaszeri et al., 2006]. In addition, 
transitional B cells as well as plasmablasts and plasma cells are known to downregulate CD45 
and would therefore not be excluded in the used sorting protocol [Zikherman et al., 2012].  
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Figure 4.11 CD10 staining reveals a stromal component within the CD49fhi/EpCAM− population. 
(A) Heatmap: expression values of the top 20 significantly (FDR<10%) upregulated genes in B− samples versus 
B+ samples with corresponding fold-changes. Red (high) and blue (low) indicates log2 expression values. Scale 
bar is in log2.  
(B) GO term analyses: selected significantly enriched GO terms (P<0.01) associated with genes differentially 
regulated between B− and B+ populations (FDR<10%, FC>3×).  
(C) Bright-field microscopy: representative images of B+ and B− cells cultured in 2D in the presence of 10 μM 
Forskolin at day 7/12 of culture (donor M10). Scale bar: 200 μm.  
 
In summary, these considerations suggest that the CD49fhi/EpCAM− population contains a 
stromal component which is negative for CD31 and CD45. As a result, using CD10 as a cell 
surface marker does not enrich regenerative cells within a basal population, but instead leads 
to purification of the basal population from stromal cells. While revealing the presence of a 
stromal fraction within the CD49fhi/EpCAM− basal population, it should be noted that these 
results do not exclude the presence of a rare population of CD10−/CD49fhi/EpCAM− 
mammary epithelial cells. At day 7 of culture in regular 2D polystyrene cell culture plates, B+ 
cells had already built cohesive epithelial islands, while only few adherent cells could be 
detected in B− cell cultures (Figure 4.11C). However, after another five days, the B− cells 
grew out to generate epithelial colonies morphologically similar to those generated by the B+ 
cell population (Figure 4.11C). It remains to be tested whether these colonies are derived from 
contaminating epithelial cells or whether the B− population indeed contains a small 
population of CD10−/CD49fhi/EpCAM− epithelial cells. Either way, these results suggest that 
the B− population is mainly composed of stromal cells, including vascular and lymphatic 
endothelial cells as well as B and T cell lymphocytes, while a small epithelial component 
cannot be excluded.  
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4.2.6 CD49f+/EpCAM+ luminal progenitor cells exhibit limited TDLU-like structure-
forming potential 
As described above, the size of the CD49f+/EpCAM+ LP cell population showed strong 
positive correlation with sphere formation and moderate negative correlation with branched 
structure formation (Figure 4.8B,C). Based on these data, LP cells predominantly form 
spheres. In line with this, ELDA revealed that regenerative potential is enriched within the B+ 
population over the basal, B− and LP population (Figure 4.9). In line with this, LP cells from 
donor M9 did not generate any branched structures. Notably however, LP cells from donors 
M8 and M10 displayed limited TDLU-like structure formation with a B-SFU of 1/2134 and 
1/4219, respectively (compare with Figure 4.9A). Summarizing the values from donors 
M8/M9/M10, ELDA revealed an overall B-SFU for LP cells of 1/5122 (Figure 4.9A). 
Importantly, this frequency could not be explained by contamination with B+ cells during the 
sorting procedure, as for all sorts, contamination with these cells was determined to be less 
than 1% (Figure 4.12A). Considering that ~1/413 B+ cells generates a branched structure and 
contamination within LP cells is ~1%, at least 40,000 LP cells (413 B+ cells*100) would have 
to be seeded in order to obtain one TDLU-like structure, resulting in a B-SFU of ~1/40,000. 
Conversely, contamination with B+ cells would have to be ~8% (413/5122*100), in order to 
obtain a B-SFU of 1/5122. While TDLU-like structure formation cannot be explained by 
contamination with B+ cells, there are two other possibilities: Either the LP population 
contains rare TDLU-like structure forming cells or LP cells acquire TDLU-like structure 
forming ability upon isolation from the MG, for example by de-differentiation. In accordance 
with our finding, it has been described previously that human LP cells can give rise to 
epithelial structures containing both luminal and basal cells when transplanted under the renal 
capsule or into a cleared humanized mammary fat pad [Keller et al., 2010, Shehata et al., 
2012].  
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Figure 4.12 CD49f+/EpCAM+ luminal progenitor cells exhibit limited TDLU-like structure-forming 
potential 
(A) Reanalysis of sorted LP cells from donors M8, M9 and M10 used for extreme limiting dilution analysis 
(ELDA) in Figure 4.9. 
(B) Stereo and Bright-field microscopy: representative images of structures derived from LP and B+ sorted cells 
(donor M8) from ELDA experiment in Figure 4.9. Scale bar: 200 μm.  
(C) Confocal microscopy: representative images of structures derived from LP and B+ sorted cells (donor M8). 
CK8/18 (green), vimentin (red), DAPI (blue). Scale bar: 100 μm.  
 
 
To compare the cellular identity of TDLU-like structures generated by B+ and LP cells, 
confocal microscopy was performed (Figure 4.12B,C). As expected, TDLU-like structures 
generated by B+ cells expressed vimentin at basal positions and occasionally contained 
CK8/18 positive cells in luminal positions, indicating that in these positions cells were 
maturing towards a luminal identity.  
Strikingly, both spheres and branched structures generated by LP cells showed strong 
expression of the luminal marker CK8/18, also at basal positions, while vimentin could not be 
detected (Figure 4.12C). These data suggest that LP cells are able to maintain luminal 
characteristics while undergoing branching morphogenesis. However, in some cases, areas of 
CK8/18 negative vimentin positive cells emerged that appeared disordered and invasive and 
were located right next to CK8/18+ areas. The close location suggested that these CD8/18−, 
vimentin+ cells were emerging from CD8/18+ vimentin− colonies (Figure 4.12C, right).  
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In summary, these results suggest that the LP cell compartment is plastic and can acquire 
regenerative capacity which can be morphologically similar to regeneration seen by B+ cells. 
However, on the cellular level, LP differ from B+ cell derived branched structures in that the 
generated structures continue to express luminal markers while lacking expression of 
vimentin. The appearance of invasive areas negative for luminal markers raise the question 
whether plasticity observed in LP cells is representative of normal regeneration or of illicit 
dedifferentiation. 
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4.3 B+ cell-derived TDLU-like structures contain cells with luminal 
features and display functionality  
As described above, MaSCs/bipotent progenitors of the mouse MG are defined by the ability 
of a single cell to regenerate a cleared mammary fat pad in serial transplantation [Shackleton 
et al., 2006, Stingl et al., 2006]. In this case, regeneration includes the ability of a single 
mammary epithelial cell to give rise to differentiated and functional progeny: The regenerated 
murine mammary epithelial tree contains cells of both major mammary lineages, luminal and 
basal. In addition, in response to hormones released in pregnancy, the regenerated cells 
exhibit functional features by being able to produce milk proteins [Shackleton et al., 2006, 
Stingl et al., 2006]. To assess the regenerative ability of HMECs cultured in floating collagen 
gels analogous to the regenerative ability of murine MECs transplanted into a cleared 
mammary fat pad, I determined whether B+ cell-derived TDLU-like structures contain cells 
of the luminal lineage and display functionality.  
 
4.3.1 B+ cell derived TDLU-like structures contain cells with luminal features 
To test whether B+ cell derived TDLU-like structures generated in floating collagen gels 
contain cells of the luminal lineage, similar to mammary epithelial trees regenerated by 
murine MaSCs/bipotent progenitors, I sorted B+ and LP cells from freshly isolated HMECs 
and seeded them into floating collagen gels. After 20 days, collagen gels were fixed and 
embedded in paraffin for immunohistological detection of the basal cell marker p63 and 
luminal markers GATA3 and CK18. Structures generated by LP cells were negative for p63 
and positive for both GATA3 and CK18 (Figure 4.13A), confirming the luminal identity of 
these cells and demonstrating the maintenance of luminal features during culture in floating 
collagen gels. Strikingly, all B+ cell derived TDLU-like structures expressed p63 at basal 
positions and showed GATA3 staining at luminal positions (Figure 4.13A), reflecting 
polarization of the human MG in situ and suggesting that there is a degree of luminal 
differentiation in B+ cell derived structures. Notably, I could not detect any expression of 
CK18 in B+ cell derived structures which might be explained by expression of CK18 only 
later in the process of luminal differentiation.  
These data suggest that B+ cells cultured in floating collagen gels give rise to cells with 
luminal features analogous to the MaSCs/bipotent progenitors of the mouse MG. However, 
for mature luminal differentiation to occur, the culture period might have to be increased 
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and/or the culture medium might have to be optimized by addition of factors that promote 
terminal luminal differentiation.  
 
  
 
 
Figure 4.13 B+ cells give 
rise to GATA3+ cells. 
(A) Immunohistochemistry: 
expression of p63, GATA3 
and CK18 in representative 
sections of structures derived 
from LP or B+ cells (donor 
M10), fixed at culture day 20. 
For LP and B+, six and five 
fields of view were analyzed, 
respectively. Scale bar: 50 
μm. 
 
4.3.2 B+ cell-derived TDLU-like structures display functionality 
Contraction is a crucial function of myoepithelial/basal cells in vivo as it is required to 
promote the release of milk during lactation [Gudjonsson et al., 2005, Sopel, 2010]. Thus, to 
determine functionality, I aimed to assess the ability of TDLU-like structures to contract.  
One of the most commonly used contraction assays is based on the ability of myofibroblasts 
to contract floating collagen gels. For this assay, fibroblasts are seeded into floating collagen 
gels and changes in gel size are determined for a certain period of time, from which a 
contraction index can be determined [Li et al., 2011]. Thus, the contraction assay described 
above was used to determine the functionality of TDLU-like structures. B+ and LP cells were 
seeded into floating collagen gels and were cultured for 12 days to allow for the formation of 
TDLU-like structures and spheres, respectively. Notably, during this initial time period of 12 
days, the structures formed and increased in size but no contraction of the gels was observed. 
After 12 days, gels were photographed every 24 hours for two more days to determine 
changes in gel size (Figure 4.14A). At the end of the time course, gels containing B+ cells 
were contracted to half of the initial size, while gels containing LP cells did not change in size 
(Figure 4.14A,B).  
These results show that B+ cell derived TDLU-like structures exhibit functional features by 
contracting floating collagen gels. The fact that contraction of gels could only be observed 
after an initial culture period of 12 days suggests that maturation and contractility of TDLU-
like structures develop concomitantly. In addition, the lack of contraction in gels containing 
LP-derived spheres is not surprising, as it reflects the non-contractile function of LP cells.   
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To prove unequivocally that the observed changes in gel size were due to cellular 
contractility, I treated the cultures with factors known to increased cellular contractility. 
Oxytocin is a peptide hormone which is released by the posterior pituitary axon terminals 
upon suckling of the newborn and is required for milk-ejection from the MG. Specifically, it 
has been reported to induce contraction of myoepithelial mammary epithelial cells [Crowley 
et al., 1992, Reversi et al., 2005]. However, addition of oxytocin to TDLU-like structures did 
not result in increased contraction (data not shown). A reason for this might be insufficient 
stability of oxytocin in cell culture or requirement of additional, yet unidentified 
auto/paracrine factors, as has been suggested in the literature [Sopel, 2010]. TGFβ1 is a 
morphogen which promotes contractility of fibroblasts by inducing expression of alpha 
smooth muscle actin (αSMA) [Lijnen et al., 2003]. To determine whether the contraction of 
basal/myoepithelial cells could be further induced by addition of TGFβ1, I treated TDLU-like 
structures and spheres with 2.0 ng/ml recombinant TGFβ1 once at day 12 of culture. After 2 
more days, this single treatment had increased the contraction of gels containing B+ cell 
derived TDLU-like structures by 2-fold (Figure 4.14B). In accordance with the non-
contractile function of LP cells, TGFβ1 had no or only slight effects on the size of gels 
containing LP cell derived spheres. A slight reduction in gel size upon TGFβ1-treatment was 
seen in gels containing LP cells from donor M3. The small reduction in gel size might be 
explained by the fact that these gels contained a low number of TDLU-like structures which 
might have been the result of sort impurities or LP cell dedifferentiation.  
It should be noted that TGFβ1 is growth inhibitory for various cell types, including HMECs 
[Barcellos-Hoff et al., 2000]. To exclude that growth inhibition was underlying the observed 
effects on gel size, the number of cells contained within a gel were counted at the end of the 
experiment. Importantly, cell numbers were equal between all conditions showing that gel 
differences in gel size were not caused by potential growth inhibitory effects of TGFβ1 
(Figure 4.14C).  
To confirm contraction at the single cell level, f-actin fibers and nuclei were stained with 
phalloidin and DAPI, respectively. Measurement of cell diameter based on the f-actin staining 
confirmed that cells treated with TGFβ1 were smaller than control cells (Figure 4.14D), 
supporting the finding that TGFβ1 promotes contraction of B+ cell derived TDLU-like 
structures. 
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Figure 4.14 B+ cell-derived TDLU-like structures recapitulate functional aspects of the mammary gland.  
(A) Bright-field microscopy: representative images of control and TGFβ1-treated gels containing B+ or LP cells 
from (B). 
(B) Gel contraction: size of gels containing LP or B+ cells (donors M3, M10) at day 12 of culture (indicated as 
day 0) imaged for 2 days. 400 μl collagen gels, 3x103 B+ cells or 1x104 LP cells seeded per gel. Gels were 
treated with 2.0 ng/ml of TGFβ1 at day 0 and gel size was assessed for two more days. Gel size is plotted 
relative to day 0. Lower panel: bar graphs of gel size at day 2 as percentage of day 0. n=12 gels/condition. 
(C) Average number of cells/gel at the end of analysis shown in (A,B). Gels containing LP cells (donor M10) 
were pooled and counted.  
(D) Contraction of individual cells. Confocal microscopy (left): B+ cell derived structures (donor M8) were 
treated with TGFβ1 as in (B), and stained with Phalloidin to visualize F-actin (white) and DAPI (blue). Areas 
outlined are shown at higher magnification on the right. Scale bar: 100 μm. Cell size was determined for 30 cells 
of three different structures/condition using the ImageJ area tool. 
(B,C,D) Data are shown as mean ± standard deviation (s.d.).  
n.s., not significant; n.a., not applicable.  
 
In conclusion, a functional feature of myoepithelial cells, namely contractility, can be 
recapitulated in floating collagen gels and further stimulated by treatment with TGFβ1. This 
assay might prove useful in the identification and characterization of MaSCs/bipotent 
progenitor cells as it was recently reported that murine MaSCs belong to the myoepithelial 
cell population with contractile function [Prater et al., 2014].  
Results 
68 
 
4.4 Matrix compliance promotes TDLU-like structure formation and 
luminal differentiation 
4.4.1 TDLU-like structure formation depends on matrix compliance 
As discussed above, B+ cells giving rise to TDLU-like structures exhibited contractile 
function in floating collagen gels. Thereby, the question emerged whether gel-contraction was 
simply a result of TDLU-like structure formation, or whether contraction was required for the 
generation of TDLU-like structures by providing force-feedback to the cells.  
To address this question, I cultured B+ cells in floating collagen gels, representing a 
soft/compliant environment, in collagen gels that were left attached to the culture dish, 
representing a stiff/rigid environment, and in attached collagen gels that were detached once 
structures had formed (Figure 4.15A). While floating collagen gels promoted the formation of 
TDLU-like structures with prominent alveoli at their tips, structures formed in attached 
collagen gels lacked alveoli formation (Figure 4.15B). Instead, the tips of these structures 
contained elongated cells whose protrusion pointed away from the structure towards the 
surrounding collagen, representing an invasive phenotype (Figure 4.15B, smaller image).  
Strikingly, flotation of previously attached gels caused loss of invasive morphology and 
formation of alveoli within 24 hours (Figure 4.15B). This result shows that HMECs respond 
to changes in the physical environment in a fast manner.  
To further describe the different morphologies observed in floating versus attached gels, the 
number of primary, secondary, tertiary and quaternary side branches was determined for the 
different conditions (Figure 4.15C). This revealed that in addition to the complete lack of 
alveoli, structures formed in attached collagen gels had a 2.6 fold greater number of side 
branches (Figure 4.15C). 
In conclusion, these results highlight the importance of force-feedback mechanisms between 
normal HMECs and the physical environment. A rigid/attached collagen matrix which cannot 
be contracted promotes the inherently invasive mechanisms of ductal elongation and side-
branching while a compliant/floating collagen matrix promotes alveologenesis.  
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Figure 4.15 Matrix compliance in floating collagen gels is required for alveologenesis. 
(A) Experimental layout: freshly isolated HMECs were seeded into collagen I gels, which were immediately 
detached to float (left) or left attached to the cell culture dish (middle, right). Once branched structures had 
formed, some attached gels were detached (right).  
(B) Bright-field microscopy: representative images of HMEC-derived branched structures 
(donor M8), cultured according to (A) and imaged for 60 h, starting at day 13 of culture. Smaller images: detail 
of area indicated by asterisk. Scale bar: 500 μm. 
(C) Quantification of side branches: representative image with primary, secondary and tertiary side branches 
indicated by red, blue and yellow lines, respectively. The graph shows the number of side branches/structure in 
attached and floating collagen gels at day 13 of culture for five structures/condition (donor M8). Data are shown 
as mean ± standard deviation (s.d.).  
 
4.4.2 TDLU-like structure formation depends on the cell’s ability to contract in a 
compliant environment 
 
As shown above, contraction of collagen gels was required for alveologenesis and TDLU-like 
structure formation. Next, I tested whether cellular contractility of cells was required for 
alveologenesis. Thus, freshly isolated HMECs were seeded into attached collagen gels and 
once structures had formed, gels were treated with Blebbistatin or Y-27632, every 24 hours to 
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prevent cellular contraction. Blebbistatin is a small molecule inhibitor which prevents 
contraction by directly binding to and inhibiting myosin II-ADP-Pi complex, thereby 
interfering with phosphate release, blocking myosin II in an active detached state [Kovács et 
al., 2004]. As discussed above, Y-27632 is a specific inhibitor of rho-associated protein 
kinase (ROCK), a kinase promoting actin-myosin contraction by phosphorylation of a variety 
of targets including MLC and LIM kinase [Riento et al., 2003]. After treatment with either 
Blebbistatin or Y-27632, the gels were detached immediately. As expected, detachment of 
control gels containing untreated TDLU-like structures led to a decrease in gel size to about 
70% of the initial size within 4 days, suggesting that cellular contractility was functional. In 
contrast, gels containing TDLU-like structures treated with either Blebbistatin or Y-27632 
contracted to only 90% and 80% of the initial size, respectively (Figure 4.16A). Contraction 
of gels treated with Y-27632 was not correlated with differences in cell proliferation/survival, 
as cell numbers at the end of analysis were equal between control and Y-27632 conditions 
(Figure 4.16B). In contrast, gels treated with Blebbistatin contained significantly less cells at 
the end of analysis. However, Blebbistatin-treatment inhibited detachment-induced reduction 
in gel size already at much earlier timepoints (24, 60 h after detachment), suggesting that this 
effect would also have occurred independent of proliferation/survival (Figure 4.16A). As 
observed before, untreated structures developed alveoli within 24-hours after detachment 
(Figure 4.16C). In contrast, alveologenesis was prevented in structures treated with either 
Blebbistatin or Y-27632. In summary, these results suggest that formation of alveoli is 
promoted by actin-myosin based contraction of TDLU-like structures. 
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Figure 4.16 Actin-myosin based contraction in floating collagen gels is required for alveologenesis. 
(A) Contraction of collagen gels: HMECs from donor M10 were grown in attached collagen gels. Once branched 
structures had formed, gels were detached (day 13 of culture) and treated with 10 μM Blebbistatin or 5 μM Y-
27632 every 24 hours. The size of the gels was determined directly after detachment (0 hours), and after 24, 60 
and 110 hours. Gel size is plotted relative to the time point of detachment (0 hours). 400 μl collagen gels, 3x103 
cells seeded per gel. n=16 gels/condition.  
(B) Quantification of the average number of cells per gel at the end of analysis shown in (A), n=4. Data are 
shown as mean ± standard deviation (s.d.).  
(C) Bright-field microscopy: representative images of HMEC-derived branched structures from (A) Smaller 
pictures are details of areas indicated with asterisk. Scale bar: 500 μm.  
n.s., not significant  
 
4.4.3 Acquisition of luminal features and correct polarization of TDLU-like structures 
depend on matrix compliance  
As shown above, active contraction of floating collagen gels by B+ cell derived structures is 
required for the formation of alveoli which are the functional, milk producing units of the MG 
associated with luminal differentiation. To investigate whether matrix compliance promoted 
not only alveologenesis but also luminal differentiation at the molecular level, I cultured B+ 
cells in floating, attached and attached collagen gels that were detached once TDLU-like 
structures had formed. TDLU-like structures were analyzed by immunofluorescence and 
qPCR for the expression of basal/luminal and polarization markers.  
Results 
72 
 
In TDLU-like structures from floating and attached-to-floating collagen gels, cells of the outer 
layer were positive for the basal marker p63, while some cells at inner positions had acquired 
expression of luminal markers GATA3 and ZO-1 (Figure 4.17A,B). This finding confirms the 
previous observation that B+ cells give rise to cells with luminal features in floating collagen 
gels and that TDLU-like structures recapitulate lineage marker expression in situ. In addition, 
this finding indicates that luminal differentiation is promoted by matrix compliance.  
In contrast, in structures grown in attached collagen gels, expression of p63 was not restricted 
to cells at basal positions and the expression of luminal marker GATA3 was observed only in 
rare cells in focal positions, while ZO-1 could not be detected (Figure 4.17A,B). These results 
suggest that culture in attached collagen gels impairs luminal differentiation.  
Supporting these observations, transcript levels of luminal markers ELF5 and ZO-1 (TJP1) 
were not detectable/lower in attached collagen gels (Figure 4.17E), while GATA3 mRNA was 
expressed at similar levels in all conditions. The latter finding is in contrast to the observation 
that cells expressing GATA3 protein were detected at luminal positions in TDLU-like 
structures of floating and attached-to-floating collagen gels. These contrasting results suggest 
that flotation either promotes the luminal positioning of pre-existing GATA3+ cells or that it 
promotes the upregulation of GATA3 in only a small number of cells at luminal positions. In 
both cases, changes in GATA3 expression might not be detected by the assessment of overall 
GATA3 transcript levels.  
TDLU-like structures of both floating and attached-to-floating collagen gels expressed 
basement membrane receptor integrin-α6 at strictly basal position (Figure 4.17C). In attached 
collagen gels, integrin-α6 was expressed at similar levels, but its expression occasionally 
extended towards more luminal positions. Expression of the basement membrane component 
and ligand for integrin-α6, laminin, was observed in TDLU-like structures of both floating 
and floating to attached gels. In contrast, expression of laminin was weak in branched 
structures of attached collagen gels (Figure 4.17C). These results indicate that matrix 
compliance promotes polarized expression of basement membrane components and their 
receptors.   
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Figure 4.17 Matrix compliance in floating collagen gels is necessary for luminal differentiation of TDLU-
like structures. 
(A) Confocal microscopy: representative images of HMEC-derived branched structures (donor M8), cultured 
according to Figure 4.15A. Staining: p63 (red), GATA3 (green), and DAPI for nuclei (blue). Scale bars: 50 μm. 
(B) Confocal microscopy: representative images of HMEC-derived branched structures from same origin as 
in (A). Staining: p63 (red), ZO-1 (green), and DAPI for nuclei (blue). Scale bars: 50 μm. 
(C) Confocal microscopy: representative images of HMEC-derived branched structures from same origin as 
in (A). Staining: integrin-α6 (red), laminin (green) and DAPI for nuclei (blue). Scale bars: 50 μm. 
(D) Confocal microscopy: representative images of HMEC-derived spheres (donor M8), cultured in floating and 
attached collagen gels, at day 14 of culture. p63 (green), ZO-1 (red), integrin-α6 (red), laminin (green), DAPI 
(blue). Scale bar: 100 μm.  
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(E) RT-PCR: ELF5 and TJP1 (ZO-1) mRNA expression in B+ and LP cell derived structures from donors M3, 
M8 and M10, cultured in attached and floating collagen gels. n=3. Data are shown as mean ± standard deviation 
(s.d.). n.d., not detectable 
 
In LP derived spheres, high rigidity of attached collagen gels did not have any effect on the 
morphology and expression of luminal markers at the protein and mRNA level 
(Figure 4.17D,E). Considering that these cells are non-contractile and based on our 
observation that LP cell derived structures did not contract floating collagen gels, these results 
indicate that differentiation of LP cells is independent of the physical environment. 
In summary, compliant/floating collagen gels promote correct polarization and acquisition of 
luminal features of B+ cell derived TDLU-like structures while differentiation of LP cell 
derived structures seem to be independent of matrix compliance. 
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4.5 Forskolin promotes TDLU-like structure formation by B+ and LP cells 
4.5.1 Forskolin promotes TDLU-like structure formation by B+ and LP cells 
Forskolin increased the number of TDLU-like structures generated by bulk primary HMECs, 
and was therefore used as standard supplement in the culture of HMECs (Figure 4.2B,C). 
Sorting of freshly isolated HMECs revealed that TDLU-like structure forming ability was 
predominantly contained within the B+ population (B-SFU = 1/413; Figure 4.9A). However, 
also LP cells exhibited limited TDLU-like structure forming potential (B-SFU = 1/5112; 
Figure 4.9A). Next, I addressed whether the addition of Forskolin increased B-SFU of LP and 
B+ cells in an equal manner, or whether its effect was more pronounced in one subpopulation. 
Thus, I seeded freshly isolated B+ and LP cells from 3 donors into floating collagen gels in 
limiting dilution in the presence or absence of Forskolin. After a culture period of 15 days, 
gels containing at least one TDLU-like structure were quantified. ELDA revealed that 
Forskolin significantly increased B-SFU of both LP and B+ cells (Figure 4.18A). Specifically, 
Forskolin treatment increased B-SFU of B+ and LP cells by  ̴1.7-fold and  ̴6.1-fold, 
respectively. However, B-SFU of B+ cells was generally much higher than B-SFU of LP cells 
both in the absence (̴91.9-fold) or presence (̴25.4-fold) of Forskolin (Figure 4.18A).  
By comparing B-SFU in the absence versus presence of Forskolin, it can be calculated how 
many cells acquired B-SFU upon Forskolin treatment: 
In LP cells, Forskolin treatment raised B-SFU 6.1-fold from 1/40992 to 1/6777 cells. Put 
differently, B-SFU was raised from 1/40992 to 6.1/40992 cells. This means that 5.1 among 
40992 (= 1/8038) cells had newly acquired TDLU-like structure forming ability in the 
presence of Forskolin.  
In B+ cells, Forskolin treatment raised B-SFU 1.7-fold from 1/446 to 1/267 cells. Put 
differently, B-SFU was raised from 1/446 to 1.7/446 cells. This means that 0.7 among 446 (= 
1/637) cells had acquired TDLU-like structure forming ability in the presence of Forskolin. 
Thereby, the total number of cells which newly acquired TDLU-like structure forming ability 
upon treatment with Forskolin was greater in the B+ than in the LP population. 
Importantly, the Forskolin induced increase in B-SFU of the LP population could not be 
explained by contamination with B+ cells during the sorting procedure. In this experiment, 
contamination of the LP population with cells from the B+ population was less than 0.5% 
among all samples (data not shown). Considering that ~1/637 B+ cells acquired branched 
structure forming ability upon Forskolin treatment and assuming a contamination with B+ 
cells of 1%, 63,700 cells of the LP population (637 B+ cells*100) would contain one B+ cell 
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which would respond to Forskolin by acquiring TDLU-like structure forming ability. 
However, it was determined that 1/8038 cells of the LP population acquired B-SFU upon 
treatment with Forskolin, indicating that cells with LP identity acquire TDLU-like structure 
forming potential upon Forskolin treatment.  
In summary, these data indicate that Forskolin treatment increases B-SFU of both B+ and LP 
cells. However, in absolute values, the effect of Forskolin on B-SFU is more pronounced in 
B+ cells than in LP cells. Based on this, the use of Forskolin as standard culture additive leads 
to an increased number of branched structures primarily from cells of the B+ population, 
which endogenously exhibits the highest B-SFU, rather than causing potentially aberrant de-
differentiation of a LP cell population. Future studies will address which cells among both the 
B+ and LP population are particularly sensitive to treatment with Forskolin and assess the 
mechanism behind acquisition of B-SFU. Considering that acquisition of B-SFU in LP cells 
might reflect aberrant de-differentiation (see Chapter 4.2.6), it will be of particular interest to 
assess the mechanisms behind acquisition of B-SFU in these cells.  
 
 
 
 
Figure 4.18 Forskolin promotes TDLU-like structure formation by LP and B+ cells.  
(A) Extreme limiting dilution analysis: Determination of branched structure-forming units by FACS sorted LP cells 
(top) and B+ cells (bottom), cultured in the presence or absence of 10 µM Forskolin (B-SFU, donors M8, M9, M10).  
Data are mean and 95% confidence intervals (CI). 
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5 Discussion 
The identification and characterization of human stem-/progenitor cells and the analysis of 
cellular plasticity have long been hampered by the limited applicability of murine in vivo 
assays and the failure of currently used 2D and 3D in vitro assays to recapitulate the 
histological architecture and functionality of the human MG. Three-dimensional organotypic 
assays aim to mimic the normal tissue environment and thereby allow (single) adult stem-
/progenitor cells to generate organoids containing all cell types and exhibiting functionality of 
the specific tissue [Clevers, 2016].  
Here, I have developed a novel organotypic culture system in which single primary HMECs 
cultured in floating collagen I gels generate structures which resemble TDLUs, the functional 
units of the human MG in situ. The TDLU-like structures contain both cells with basal and 
luminal marker expression and display functionality by contracting. Using this culture model, 
regenerative capacity, cell fate and plasticity of HMECs can be modeled in vitro. In addition, 
this model provides a tool for assessing the interplay between the molecular environment and 
MG architecture, function and differentiation in the setting of normal tissue development and 
homeostasis and to identify and characterize aberrant behavior. 
 
The three major achievements of this study are:  
1.) Development of a novel organotypic culture system in which primary HMECs generate 
TDLU-like structures. 
2.) Description of lineage marker expression, polarization and functionality of TDLU-like 
structures and the dependence of these parameters on the mechanical environment.  
3.) Development of a protocol for the enrichment of TDLU-like structure forming cells which 
were found to belong to the basal lineage. 
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5.1 A novel three-dimensional culture system for the generation of breast 
organoids 
Cell lines are commonly used to study MG biology. However, immortalization and prolonged 
culture introduce genotypic and phenotypic changes and usually lead to the selection of a 
subpopulation of cells which is not representative of the original tissue [Birgersdotter et al., 
2005, Petersen et al., 1992]. In order to provide a biologically more relevant system, the 
organotypic culture system used in this study relies on normal, freshly isolated primary 
HMECs isolated from reduction mammoplasties. These cells more accurately reflect the 
cellular behavior in vivo as they are isolated from tissue samples directly before use and not 
subjected to immortalization. Thereby, they represent the cellular composition of the donor-
tissue and do not contain genetic or phenotypic aberrations which are introduced by in vitro 
immortalization. As such, they are a valuable tool to study cellular phenotypes and functions 
relevant in vivo.  
In the MG, cells grow in a 3D context where they are connected to each other as well as to the 
surrounding basement membrane and ECM. In humans, the stroma surrounding mammary 
epithelial ducts and their associated basement membrane consists of connective tissue 
proteins, most abundantly collagen I [Howard et al., 2000]. Collagen I lends structural support 
to the epithelial structure and provides binding moieties for the cells thereby affecting how 
biochemical signals are interpreted [Birgersdotter et al., 2005, Taddei et al., 2003].  
These considerations suggest that collagen I serves as a biologically relevant 3D environment 
in vitro. By taking into account previous studies showing that cells of the breast carcinoma 
cell line T47D generate tubular structures in freely floating collagen gels [Wozniak et al., 
2005], I thus chose floating gels of collagen I as biologically relevant substrate for culturing 
HMEC in vitro.   
Indeed, culture of HMECs within floating collagen I gels led to the formation of TDLU-like 
structures which resemble the functional units of the human breast in situ [Anderson et al., 
1998]. Matrigel, a basement membrane protein mix produced by a mouse sarcoma cell line, is 
another substrate commonly used for 3D-culture of mammary epithelial cells. However, it is 
derived from mouse sarcoma cells and its exact composition is not defined and varies from lot 
to lot [Benton et al., 2014]. Here, formation of TDLU-like structures was not supported in 
Matrigel, or a mixture of collagen I and Matrigel, suggesting that it represents a biologically 
less relevant substrate for HMECs than collagen I. It should be noted that in contrast to these 
data other research groups have reported successful cultivation of basal HMECs in Matrigel. 
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However, this inconsistency can be explained by different culture setups. Specifically, other 
researchers included pre-culture of single cell suspensions or have used tissue fragments or 
different culture media, the latter of which might have led to selection of a certain 
subpopulation of cells able to grow in Matrigel [Dontu et al., 2003, Villadsen et al., 2007]. In 
addition, HMEC feeder layers have been used, which are a source of signaling molecules and 
ECM proteins. Thereby, the molecular environment of the cells growing in Matrigel is 
changed which might have led to improved survival and growth [Villadsen et al., 2007]. In 
summary, floating collagen I gels rather than Matrigel allow for 3D-morphogenesis of 
HMECs in vitro and provide a growth environment resembling the tissue context of HMECs 
in vivo. Thereby, the organotypic culture system presented here will be a valuable tool to 
study cellular phenotypes and functions relevant in vivo.  
 
5.2 Critical parameters of TDLU-like structure formation 
 
The generation of TDLU-like structures described above depended on three critical 
parameters which will be discussed below: intracellular cAMP levels, physical forces of the 
ECM and cellular contractility.  
5.2.1 Intracellular cAMP levels 
cAMP is a second messenger which plays an important role in the cellular response to 
hormones and neurotransmitters. The intracellular levels of cAMP are regulated by two 
groups of enzymes: Adenylate cyclases catalyze the conversion of ATP to cAMP, while 
cyclic nucleotide phosphodiesterases (PDEs) degrade the phosphodiester bonds in cAMP, 
hydrolyzing cAMP to AMP [Rehmann et al., 2007, Sassone-Corsi, 2012]. Forskolin directly 
binds to adenylate cyclase by hydrophobic interactions, causing its continuous activation and 
increased cAMP production [Tang et al., 1998].  
Here, continuous treatment with Forskolin was found to promote TDLU-like structure 
formation in floating collagen gels. This effect might rely on the stimulation of pathways 
involved in steroid hormone signaling, which is the major driver of MG development after 
puberty, stimulating ductal elongation, side branching and alveologenesis in vivo [Brisken et 
al., 2010]. Indeed, both estrogen and progesterone signaling were found to increase 
intracellular cAMP levels in mammary epithelial cells: Daily injection of either estrogen or 
progesterone was shown to increase cAMP levels in ovariectomized mice, in which the 
ovaries, the major source of estrogen and progesterone had been removed surgically 
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[Sheffield et al., 1987]. Also in the breast cancer cell line MCF-7, estrogen was shown to 
stimulate adenylate cyclase and cAMP-regulated gene expression [Aronica et al., 1994, 
Zivadinovic et al., 2005]. On the functional level, activation of cAMP signaling by 
implantation of pellets containing Forskolin or other cAMP raising agents was shown to 
stimulate end bud development and restore duct diameter in ovariectomized mice with 
underdeveloped and regressed ductal epithelial tree [Silberstein et al., 1984]. These data 
suggest that agents raising cAMP levels can be used to replace parts of steroid hormone 
signaling. Thereby, treatment with Forskolin might be useful to promote growth and 
differentiation of HMECs in vitro. This would be a great achievement, as hormone receptor 
expression gets lost upon in vitro culture of primary HMECs.  
So far, efforts preventing the loss of steroid hormone receptor expression include culture of 
crude tissue fragments containing stromal components, which allows for HR maintenance for 
a short period in culture but does not allow for analysis of independent cells [Tanos et al., 
2013]. In addition, culture of primary HMECs in the presence of small molecule inhibitors of 
TGF-β signaling was reported to maintain ER expressing cells with functional estrogen 
signaling in 2D culture [Fridriksdottir et al., 2015]. However, these findings could not be 
reproduced in our hands (data not shown).  
Future studies should assess more closely downstream effects of cAMP signaling and the 
overlap with steroid hormone signaling. In addition, hormone receptor(s) responsible for 
cAMP signaling in mammary epithelial cells in vivo should be identified. For this the 
development of in vitro culture conditions supporting the maintenance of functional steroid 
hormone signaling in primary HMECs will be of great help.   
Treatment with Forskolin not only increased TDLU-like structure formation but also 
increased the number of times TDLU-like structures could be passaged in floating collagen 
gels. In addition, Forskolin treatment was necessary for the maintenance of an epithelial 
phenotype of HMECs cultured in 2D or 3D conditions. Furthermore, in branched structures 
were more compact and cells expressing the luminal marker Gata3+ appeared earlier in the 
center of structures in presence of Forskolin, suggesting that Forskolin promotes self-
organization. Compounds raising intracellular cAMP levels have long been known to sustain 
growth and increase proliferation of primary human and murine MECs cultured in various in 
vitro assays [Stampfer, 1982]. Therefore, some part of these effects, including increased 
TDLU-like structure formation, could be explained by increased proliferation. However, other 
effects like maintenance of epithelial cell fate, improved self-organization and compaction of 
TDLU-like structures seem to be independent on proliferation. Indeed, increased cAMP levels 
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have been associated with a variety of effects: For instance, increased cAMP levels were 
shown to induce mesenchymal to epithelial transition in mesenchymal derivatives of 
immortalized HMECs by activation of PKA [Pattabiraman et al., 2016]. In addition, increased 
levels of cAMP were shown to promote lumen formation in 3D rBM cultures of the human 
mammary epithelial cell line MCF10A by accelerating the re-distribution of integrin-α6 to the 
periphery, causing polarization of outer cells and promoting apoptosis of inner cells 
[Nedvetsky et al., 2012]. 
Future studies should dissect the downstream signaling pathways responsible for the different 
observed effects more closely. In eukaryotes, three main classes of cAMP effectors have been 
identified: protein kinase A (PKA), exchange factor directly activated by cAMP (EPAC) and 
cyclic nucleotide-gated ion channels (CNGC) [Rehmann et al., 2007]. More recently, 
additional cAMP effectors have been discovered, including popeye domain containing 
(Popdc) proteins which are involved in various physiological processes including cell-cell 
adhesion and epithelial function [Schindler et al., 2016]. It is likely that the different effects 
observed here are mediated via different cAMP effectors. Therefore, selective cAMP analogs 
and inhibitors as well as PKA and EPAC inhibitors will be used to see whether they can 
mimic or prevent the described effects of Forskolin treatment.   
As mentioned above, steroid hormones might be the physiological stimuli upstream of 
increased cAMP signaling. The classical estrogen receptors (ER) and progesterone receptors 
(PR) act as intracellular transcription factors. Upon binding to ligand, they translocate to the 
nucleus, where they bind to specific sequences of DNA either directly or indirectly via other 
transcription factors. In the cytosol, ER and PR are subject to extensive cross-talk with other 
signaling pathways: For instance, activated ER and PR can induce the membrane proximal 
Src-kinase leading to downstream signaling via epidermal growth factor receptor (EGFR), 
mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase [Tanos et al., 
2012]. In addition, other signaling pathways impinge on HRs and affect their transcriptional 
activity, coactivator interaction and nuclear localization [Tanos et al., 2012]. For example, 
PKA was shown to activate ERα-mediated transcription via cAMP [Fujimoto et al., 1994]. 
Furthermore, cAMP can be induced downstream of the membranous estrogen receptor 
GPR30 and membrane localized progestin receptors (mPRs) [Prossnitz et al., 2008]. GPR30 is 
a transmembrane G-protein coupled receptor (GPCR). Once activated by binding of estrogen, 
GPER can activate adenylate cyclase via stimulatory G-proteins [Prossnitz et al., 2014]. 
Indeed, GPER was shown to be required for estrogen-mediated generation of cAMP [Filardo 
et al., 2002]. mPRs are members of the progestin and adiponextin Q receptor family which are 
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similar to GPCRs in that they are 7-transmembrane proteins and activate G-proteins and their 
downstream target adenylate cyclase [Dressing et al., 2011]. GPER and mPRs are therefore 
strong candidates in the search for hormone receptors upstream of the cAMP effects observed 
here. Future studies should therefore assess whether GPER and mPR signaling can cause 
increased TDLU-like structure formation similar to Forskolin. For this, GPER-selective 
agonists like G-1 and antagonists like G36, as well as mPR specific agonist can be used 
[Bologa et al., 2006, Dennis et al., 2011, Kelder et al., 2010].  
5.2.2 Physical forces of the extracellular matrix and cellular contractility 
Besides Forskolin, matrix compliance and cellular contractility were found to be crucial 
parameters for TDLU-like structure formation and cellular differentiation. Specifically, the 
development of alveoli-like buds and differentiation towards the luminal lineage were only 
observed in floating/compliant collagen gels but not in attached/rigid collagen gels. In 
addition, the use of small molecule inhibitors Y-27632 and Blebbistatin revealed that within 
floating/compliant gels both processes depended on actin-myosin based contraction.  
Consistent with these findings, it has previously been reported that matrix rigidity affects the 
growth, morphogenesis and differentiation of mammary epithelial cells in vitro: Matrices with 
high stiffness as a result of collagen concentration, crosslinking, matrix attachment or 
interpenetrating polymer networks were shown to disrupt normal morphogenesis and favor 
the generation of multicellular structures with a malignant/invasive phenotype [Chaudhuri et 
al., 2014, Levental et al., 2009, Paszek et al., 2005, Provenzano et al., 2009, Wozniak et al., 
2003].  
In addition, maintenance of luminal lactational differentiation of mammary epithelial cells 
from pregnant/pre-lactating mice was maintained only on compliant/floating but not on 
rigid/attached collagen gels [Emerman et al., 1977, Streuli et al., 1990].  
Indeed, I observed that rigid/attached collagen gels caused persistent elongation and increased 
formation of side branches of basal-cell derived branched structures. In contrast, the 
formation of spheres by luminal progenitor cells was not affected by increased rigidity in 
attached collagen gels. In accordance with these data, the process of increased elongation and 
formation of side branches has been related to a basal epithelial program in invasive breast 
cancer using collagen gels as experimental tool [Cheung et al., 2013].  
High matrix stiffness is observed in breast tumors and has been linked to tumor progression 
and invasion [Levental et al., 2009, Paszek et al., 2005, Provenzano et al., 2009]. Notably, the 
compression modulus of breast tumor tissue is comparable to the compression modulus of 
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stiff collagen gels with a concentration of 4 mg/ml [Paszek et al., 2005]. The fact that I 
observe persistent elongation and increased formation of side branches in attached/rigid 
collagen gels suggest that the responsiveness of breast cancer cells to the physical 
environment is conserved in normal mammary epithelial cells and plays a role in normal MG 
development/morphogenesis. Indeed, it has been reported that normal tissue behavior depends 
on tensional homeostasis of exogenous forces generated by the cells themselves and 
endogenous forces from the outside which are transmitted via the cytoskeleton [Paszek et al., 
2010]. Focal Adhesions, clusters of integrins which physically connect the cell to the ECM 
are the principal mediators of tensional homeostasis, balancing endogenous and exogenous 
forces to generate a favorable environment for cell function [Provenzano et al., 2009]. In 
MaSCs, endogenous forces might be particularly important, since these cells display 
contractility [Prater et al., 2014]. As described above, here I have shown that endogenous 
contractility regulates invasion into collagen gels and is required for generation of alveoli and 
luminal differentiation in floating collagen gels.  
Notably, generation of alveoli by HMECs in floating collagen gels was further increased by 
the addition of Forskolin. As discussed above, Forskolin is known to promote the distribution 
of integrin-α6 to the periphery, thereby accelerating the polarization of MCF10A cells 
cultured in 3D rBM cultures [Nedvetsky et al., 2012]. Importantly, staining of laminin, the 
receptor for integrin-α6, was only detected in structures grown in floating but not attached 
collagen gels. Increased generation of alveoli in floating collagen gels treated with Forskolin 
might thus be caused by increased adhesion to laminin via integrin-α6. Thereby, the effects of 
flotation, cellular contraction and Forskolin might be based on anchorage of HMECs to the 
basement membrane, as the basis to establish basal polarity supporting the formation of 
alveoli.  
Future studies will aim at a deeper understanding of the role of matrix rigidity, cellular 
contractility and cAMP signaling on morphogenesis and differentiation of HMECs and their 
relevance in normal development as well as pathological processes. It should be noted that 
with the current conditions, luminal differentiation in B+ cell derived TDLU-like structures 
was not complete, as ZO-1 and K18 staining were only rarely observed and the structures 
were not responsive to hormones (data not shown). Thus, a first step should consist of further 
improvement of culture conditions to support terminal differentiation of luminal cells.  
In vivo, the MG only terminally differentiates during pregnancy and lactation [Howard et al., 
2000, Russo et al., 2004], suggesting that culture conditions should aim to mimic the 
signaling environment during this developmental step.  
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It is known that the hormones progesterone and prolactin are involved in luminal 
differentiation and milk production [Brisken et al., 1999, Brisken et al., 2010, Gallego et al., 
2001]. Downstream of progesterone and prolactin signaling, increased expression of cyclinD1 
regulates proliferation of PR+ cells [Beleut et al., 2010, Hennighausen et al., 2005]. In 
addition, both hormones were shown to induce transcription of Receptor activator of nuclear 
factor kappa-B ligand (RANKL) has been implicated in increased expression of Elf5 in 
luminal progenitor cells, proliferation of the Elf5 expressing population as well as 
lobuloalveolar differentiation and production of milk protein [Lee et al., 2013]. Importantly, 
Elf5 seems to be a master regulator of terminal luminal differentiation, alveolar 
morphogenesis and milk production as knock-out of Elf5 prevents development of the 
secretory alveolar epithelium during pregnancy while overexpression of Elf5 in virgin mice 
led to precocious alveolar differentiation and milk secretion [Oakes et al., 2008].  
In addition to these hormone regulated signaling pathways, signals from basal cells might be 
required for terminal luminal differentiation. Specifically, it was shown that expression of 
Nrg1 as direct transcriptional target of p63 in K14+ basal cells, led to activation of Erbb4 
receptor and downstream STAT5A signaling in luminal cells, which was required for luminal 
proliferation and differentiation during pregnancy [Forster et al., 2014]. Notably, both 
prolactin and Neuregulin/Nrg1 signaling cause activation and nuclear translocation of STAT5, 
suggesting the importance of this pathway in luminal differentiation [Forster et al., 2014, 
Hennighausen et al., 2005]. Therefore, these signaling pathways must be considered in efforts 
to generate culture conditions supporting terminal luminal differentiation.  
5.3 Identification, quantification and enrichment of regenerative HMECs 
 
Identification and characterization of human and murine MaSCs/progenitors is a major focus 
of MG research. It is the basis to understand cellular hierarchies and analyze normal and 
aberrant differentiation processes.  
5.3.1 Identification and quantification of regenerative HMECs 
Adult/somatic stem cells are defined by the ability to self-renew and to differentiate into 
specialized progeny. In the mouse, the stem cell character of MECs can be tested by 
transplanting these cells into the fat pad of recipient mice cleared of endogenous epithelium 
[Shackleton et al., 2006, Stingl et al., 2006]. There, the ability to give rise to differentiated 
progeny is reflected by the regeneration of a mammary epithelial tree containing cells of both 
major mammary lineages, luminal and basal. Serial transplantations allow assessment of the 
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self-renewal ability of the detected MaSCs. Importantly, by transplanting the cells in limiting 
dilution up to doses in which no regeneration of the mammary fat pad is observed, the rate of 
cells with stem cell characteristics can be inferred [Hu et al., 2009].  
Here, I have developed a tool to detect HMECs with regenerative capacity by their ability to 
generate TDLU-like structures containing cells with basal and luminal characteristics in 
floating collagen gels. For quantification of these regenerative cells, I have performed 
extreme limiting dilution analysis (ELDA) as described by Hu et al. [Hu et al., 2009]. 
Specifically, limiting dilutions of HMECs were seeded into floating collagen gels up to doses 
in which no TDLU-like structure formation was observed, and gels containing at least one 
TDLU-like structure were quantified. Subsequently, the ELDA-software tool was used for 
mathematical analysis of the percentage of TDLU-like structure containing cultures at each 
dilution and estimation for regenerative cell frequency in the original population.  
In summary, the developed assay provides a tool for the quantification of human MECs with 
regenerative capacity which is analogous to the transplantation assay used for quantification 
of murine MaSCs. In contrast to transplantation assays, in which two mammary fat pads per 
mouse can be injected with cell suspension, the 48-well format of in vitro floating collagen 
gels allows for an increased number of replicates.  
 
5.3.2 Enrichment of regenerative HMECs 
The identification and characterization of MaSCs/progenitors is a major focus of MG research 
and cells with regenerative capacity seem to be contained within the basal lineage in both 
human and mouse (see Chapter 1.2.4). In line with the current literature, ELDA in floating 
collagen gels revealed that TDLU-like structure formation is enriched in the basal 
CD49fhi/EpCAM− basal population over the LP CD49f+/EpCAM+ population. 
Here, I looked for additional markers to further enrich for TDLU-like structure forming cells. 
CD10 is a metalloendopeptidase which cleaves and inactivates a variety of peptide hormones, 
including oxytocin, a hormone released by the pituitary gland upon breastfeeding and which 
mediates myoepithelial cell contraction to support milk release [Maguer‐Satta et al., 2011]. 
CD10 has been shown to enrich for HMECs which build mammospheres, i.e. proliferate when 
cultured in anchorage independence and give rise to colonies expressing both luminal and 
basal markers in 2D culture, both traits associated with MaSCs [Bachelard‐Cascales et al., 
2010].  
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Using CD10 as additional marker, I could show that regenerative cells were enriched within 
the CD10+/CD49fhi/EpCAM− (B+) population over the CD49fhi/EpCAM− basal population by 
approximately 7-fold, while TDLU-like structure formation was almost depleted in the 
CD10−/CD49fhi/EpCAM− (B−) population. CD10 is thus a useful marker to enrich for TDLU-
like structure forming cells. 
Importantly, gene expression analysis confirmed the basal epithelial identity of the B+ 
population. However, the genes most highly expressed in the B− population were associated 
with stromal cells, specifically CD31− and CD45− endothelial and hematopoietic cells. These 
results indicate that sorting for CD10+ basal cells did not enrich for TDLU-like structure 
forming cells within a basal population, but rather purification of the basal population by 
exclusion of stromal cells. Therefore, CD10 does not serve as a marker for MaSCs but for 
basal cells. This statement is supported by an exhaustive immunohistochemical analysis of 
cell fate markers in the human MG, which has revealed that all cells at basal positions express 
CD10 [Santagata et al., 2014].  
These data raise the question about the identity of the B− population. In vivo, high resolution 
imaging showed that in the postnatal MG, MECs are in close contract with lymphendothelium 
and blood vessels and that they are regulated together during branching morphogenesis and 
breast cancer progression [Alitalo et al., 2012, Betterman et al., 2012]. Strikingly, B− cells 
express CD49f (integrin-α6) which is the receptor for the basement membrane component 
laminin, as described above. Thereby, the B− population identified here might represent the 
lymph and vascular endothelial population which is in direct proximity of HMECs, linked to 
the basement membrane via their laminin receptors opposite to mammary epithelial cells. 
Given the role of the stromal population during MG morphogenesis and breast cancer 
progression, future studies will work on the characterization of the B− population using the in 
vitro assay described here. Specifically, by addition of this population to the assay, its 
influence on HMECs with different genetic backgrounds can be tested.  
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5.4 Regeneration in the human and murine mammary gland- MaSCs or 
unipotent progenitors? 
 
Based on transplantation studies, the mammary repopulating unit (MRU) for murine basal 
MECs (CD24med/CD49fhi or CD29hi/CD24+) is approximately 1/60, implying that one in 60 
cells has regenerative capacity [Shackleton et al., 2006, Stingl et al., 2006]. Using human 
cells, Eirew et al. have determined that approximately 1/1000 – 1/10000 basal HMECs 
(CD49f+/EpCAMlo) show regenerative capacity upon transplantation under the kidney capsule 
of immune compromised mice [Eirew et al., 2008]. In addition, here I have shown that the B-
SFU of CD49fhi/EpCAM− HMECs cultured in floating collagen gels is 1/2690 and can be 
increased to 1/413 cells by using the marker CD10.  
 
According to these data, the B-SFU of HMECs is slightly lower than the MRU of murine 
MECs determined by transplantation. Some of these differences might result from tissue 
processing and culture: naturally, due to the high amount of tissue, processing of primary 
human tissue is a time consuming process, taking approximately 48 hours, after which cells 
are usually cryopreserved. In contrast, processing of the much lower volume of murine tissue 
usually takes no more than 3 hours, after which cells can be sorted and transplanted back into 
a murine fat pad. The survival of murine MECs is further supported by the physiological 
tissue environment in which the cells are transplanted. In general, the determined MRU and 
B-SFU of murine and human basal MECs are likely underestimations, as FACS is known to 
be toxic in 50-75% of cells and unknown quantities of cells are lost during handling [Giraddi 
et al., 2015].  
Based on these considerations, a high number of both human and mouse basal MECs contains 
regenerative capacity. Importantly, the number of MRU can change depending on transplant 
and culture conditions. For instance, it was shown that the MRU of murine MECs can be 
increased if Matrigel is transplanted together with the cells [Shehata et al., 2012, Vaillant et 
al., 2011]. Furthermore, the number of murine MaSCs/progenitors was shown to increase 
upon culture in the presence of ROCKi or soluble factors produced by fibroblasts [Makarem 
et al., 2013, Prater et al., 2014]. These data show that not only a high number of both human 
and mouse basal MECs contains regenerative capacity but that the number of regenerative 
cells can vary depending on conditions during in vitro culture and transplantation. These 
findings completely contradict the concept of a rare and fixed MaSC.  
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Indeed, according to recent data, post embryonic development and homeostasis of the murine 
MG could be independent of the existence of stem cells/bipotent progenitors. As discussed in 
Chapter 1.2.4, various lineage tracing studies, the latest using thorough statistical analysis of 
multicolor lineage tracing and lineage tracing at saturation, have convincingly stated that 
unipotent rather than bipotent stem cells/progenitors mediate pubertal development, adult 
tissue homeostasis as well as pregnancy and lactation in the murine MG [Van Amerongen et 
al., 2012, Van Keymeulen et al., 2011, Wuidart et al., 2016]. Contradictory results have been 
reported from two other lineage tracing studies. However, in the first study, a high fraction 
(30%) of the mammary epithelium was labeled, which complicates the clear demarcation of 
clonal patches and could have affected their quantification [Rios et al., 2014]. In the second 
study, it was argued that protein C receptor (PROCR) marks a population of multipotent 
mammary cells. However, the PROCR+ cells showed very little clonal output, as most of the 
clones generated in the course of a 6-week tracing period during pubertal MG development 
contained only one basal and one luminal cell [Wang et al., 2015]. This limited clonal output 
is in conflict with PROCR+ cells being able to initiate the complete postnatal outgrowth of 
the murine mammary epithelium and suggests that PROCR cannot be used as marker for 
MaSCs.  
Thus, while there are multiple conflicting studies, data suggesting that postnatal MG 
development is mediated by unipotent stem cells/progenitors are convincing. However, future 
studies are needed to settle the debate on the existence or absence of multipotent MaSCs.  
The concept that an epithelial tissue is maintained by unipotent progenitors rather than 
multipotent stem cells/progenitors is not restricted to the MG. Like the MG, sweat and 
prostate glands contain an inner luminal and outer basal/myoepithelial layer of cells. Lineage 
tracing studies in these organs have led to the conclusion that all three glands originate from 
multipotent embryonic stem/progenitor cells which get replaced by unipotent luminal and 
basal progenitors in the adult tissue [Lu et al., 2012, Wuidart et al., 2016]. If the murine MG 
(and possibly the human MG) is indeed maintained by unipotent progenitors similar to the 
above named tissues, the question emerges as to why MECs exhibit regenerative capacity 
upon transplantation and in vitro culture. Two possible answers to this question are that 
regenerative capacity might be generated de novo, or that myoepithelial cells contain 
regenerative capacity which is revealed only under certain circumstances. Possible triggers for 
de novo generation or revelation of regenerative capacity include transplantation, in vitro 
culture, wounding, a changing microenvironment and genetic aberration during cancer 
development and progression. As mentioned above, first experimental data support the 
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possibility of de novo generation/revelation of regenerative capacity: After in vitro culture in 
the presence of a ROCK inhibitor, MRUs of colonies of single cell derived basal MECs was 
increased to 65%, suggesting that the majority or even entire myoepithelial/basal cell 
population contains MRU potential [Prater et al., 2014]. In addition, Matrigel culture in the 
presence of fibroblast-derived factors was shown to increase MRU formation by murine 
MECs [Makarem et al., 2013]. The acquisition/revelation of stem cell features has also been 
observed in other organs: Recent studies on epidermis, intestinal epithelium, lung and MG 
have indicated that the fate and differentiation potential of epithelial cells can change during 
tissue repair after injury and that committed epithelial lineage cells of various organs, 
including the gut, lung, stomach, liver and pancreas, can acquire stemness [Donati et al., 
2015]. For instance, Dll1+ cells in the gut are short-lived cells derived from Lgr5+ 
progenitors committed to the secretory lineage. After tissue injury by gamma-irradiation, 
these committed cells revert back to intestinal stem cells and take part in tissue regeneration. 
This conversion of Dll1+ committed cells to Lgr5+ ISCs can also be observed when Dll1+ 
cells are cultured in vitro [Blanpain et al., 2014]. Furthermore, recent studies have shown that 
unipotent epidermal progenitors can de- or re-differentiate to become multipotent: During 
normal tissue homeostasis, Lrig1+ epidermal stem cells contribute only to specific areas of 
the pilosebaceous unit, but give rise to all epidermal compartments in skin reconstitution 
assays [Donati et al., 2015, Jensen et al., 2009, Page et al., 2013].   
Thus, a very urgent question which needs to be addressed by the MaSC field is whether the 
concept of a rare mammary stem/progenitor cell is still valid. Alternatively, one could think of 
a much more plastic system relying on a population of myoepithelial cells which can 
acquire/reveal regenerative capacity only under certain circumstances. If the latter proved 
true, it would explain why the decade-long efforts of identifying a MaSC marker have not 
been successful thus far: Up to date, it is not possible to isolate a pure population of MaSCs, 
i.e. cells with regenerative capacity in transplantation assays. Instead, these cells can only be 
enriched within a population of basal cells, e.g. using the marker combination of CD49f and 
EpCAM [Shackleton et al., 2006, Stingl et al., 2006]. As most data arguing against the 
presence of adult multipotent MaSCs are derived from lineage tracing studies using mouse 
models (see Chapter 1.2.4), future studies should also aim at transferring the gained insight to 
the human system. The assay developed here will be a valuable tool for doing so. A first step 
at addressing the existence/absence of a human MaSC population could be single cell gene 
expression analyses. Specifically, single cell RNA sequencing of the B+ population exposed 
here could reveal the existence or absence of B+ subpopulations with increased or decreased 
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TDLU-like structure forming ability. Obviously, similar studies could be performed for 
murine cells. If evidence for the absence of a rare and fixed mammary stem cell population 
accumulates, current efforts focusing on the identification of novel stem cells markers should 
be brought down in favor of studies aiming at finding the triggers for the 
revelation/acquisition of stem cell features. The organotypic culture system presented here 
could be adjusted for developing an environment triggering the acquisition of stem cell traits, 
the read-out being TDLU-like structure formation. For instance, the culture system could be 
used to mimic a wounding or cancer setting by addition of inflammatory factors like 
interleukins, growth hormones, cancer associated fibroblasts or cancer cells themselves. 
 
5.5 Regenerative capacity of LP cells: aberrant de-differentiation?  
 
The vast majority of TDLU-like structure forming cells belonged to the basal population, 
however, LP cells were found to exhibit limited TDLU-like structure forming capacity (B-
SFU: 1/5122). Regenerative capacity of LP cells has been described before: When 
transplanted under the renal capsule or into a humanized fat pad of immune compromised 
mice, human LP cells can give rise to structures containing both luminal and basal cells 
[Keller et al., 2012, Shehata et al., 2012].  
Strikingly, TDLU-like structure formation of LP cells was approximately 6-fold higher in the 
presence of Forskolin than in its absence and some of the structures exhibited signs of 
aberrant (de-)differentiation. 
Notably, the frequency of TDLU-like structure formation determined in this study varied 
dramatically between LP cells from different donors. One possible explanation for this might 
be different hormone levels which depend on inter-individual differences, phase of the 
menstrual cycle and potential use of hormone replacement therapy [Brisken et al., 2010, 
Tanos et al., 2012]. Indeed, high levels of progesterone and estrogen have been associated 
with expansion of the basal and luminal cell population and increased regenerative capacity. 
In the mouse, high levels of estrogen and progesterone occurring during pregnancy or 
dioestrus, were shown to cause expansion of the luminal (CD49flo/CD24+ or CD29lo/CD24+) 
and basal MaSC (CD49fhi/CD24+ or 29hi/CD24+) population [Asselin-Labat et al., 2010, Joshi 
et al., 2010]. The increased MaSC population also exhibited increased regenerative capacity 
in transplantation assays [Asselin-Labat et al., 2010]. Molecularly, Progesterone was 
suggested to act on ER+/PR+ luminal cells causing them to secrete Wnt4 and RANKL, 
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inducing proliferation of MaSCs in a paracrine fashion [Asselin-Labat et al., 2010, Joshi et al., 
2010].  
Similarly, the size of the human LP (CD49f+/EpCAM+) population increases during the luteal 
phase of the menstrual cycle, when progesterone levels are high. In addition, the number of 
ki67+ cells is increased in the progesterone-high phase and the frequency of in vitro colony 
formation by LP cells is increased, suggesting that proliferation and differentiation are 
affected [Joshi et al., 2015]. These data show a potential link between increased hormone 
levels and regenerative capacity of LP cells, as has been observed for the basal MaSC 
population in transplantation assays.  
High levels of estrogen and progesterone have also been associated with the development of 
breast cancer. The levels of estrogen and progesterone rise and fall with every menstrual cycle 
and a high number of menstrual cycles and thus a high number of times a woman is exposed 
to high levels of estrogen and progesterone is correlated with an increased breast cancer risk 
[Apter et al., 1989, Bernstein, 2002, Kelsey et al., 1993, Trichopoulos et al., 1972]. Similarly, 
increased hormone levels due to estrogen plus progestin based hormone replacement therapy 
significantly increase breast cancer risk [Chlebowski et al., 2015]. Thus, the link between high 
levels of estrogen and progesterone and both de-differentiation/regenerative capacity and 
tumor development indicate a potential relation between these two effects.  
Indeed, breast cancer has been associated with illicit dedifferentiation of LP cells: For 
example, MG tissue of BRCA1 mutation carriers contains an expanded LP population. This 
population is likely at the origin of breast tumors which are usually classified as TNBC and 
exhibit a basal-like gene expression profile, thus changing their gene expression profile from 
luminal-like to basal-like [Lim et al., 2009, Molyneux et al., 2010]. Further evidence for illicit 
de-differentiation comes from two studies showing that expression of PIK3CAH1047R in K8+ 
luminal cells in the mouse induced reprogramming into a basal-like cell fate and increased 
regenerative capacity upon transplantation [Koren et al., 2015, Van Keymeulen et al., 2015]. 
Thus changes in the genetic background can cause de-differentiation of luminal mammary 
epithelial cells resulting in the generation of tumors with basal features. 
How can the positive link between exposure to estrogen/progesterone, increased LP 
populations, their aberrant de-differentiation and the risk of developing breast cancer be 
explained? Part of the answer could be that the cyclical expansion of the LP population 
increases the possibility of mutagenic hits, leading to aberrant de-differentiation and tumor 
development. However, here I have observed that within less than 14 days, Forskolin 
treatment increased TDLU-like structure formation by LP cells, indicating their de-
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differentiation. During this short time-period, spontaneous acquisition of mutagenic hits in a 
relevant number of cells is highly unlikely. Thereby, these data suggest that de-differentiation 
of LP cells can occur independent of mutagenic hits and can be easily induced, for instance by 
a changing signaling environment.  
Therefore, the triggers for de-differentiation of LP cells should be investigated in more detail. 
Along these lines, it should be addressed whether the Forskolin-induced increase in TDLU-
like structure formation by LP cells results from signaling pathways that also act downstream 
of estrogen and progesterone signaling. As mentioned above, GPR30 is a G-protein coupled 
estrogen receptor which, upon activation, stimulates adenylate cyclase to produce cAMP, the 
same secondary messenger as induced by Forskolin [Filardo et al., 2002]. In addition, cAMP 
can be induced downstream of mPRs [Prossnitz et al., 2008]. Furthermore, it should be 
investigated whether de-differentiation of LP cells facilitates their transformation.  
Importantly, the assay presented here not only allows for analysis of regenerative potential of 
LP cells by quantification of TDLU-like structures, but also provides a platform for the 
analysis of morphological abnormalities. For instance, it was shown that LP cell derived 
branched structures exhibited a broad range of morphologies from simple structures with only 
few branches to typical TDLU-like structures and complex branched structures with invasive 
phenotype. While most LP-derived structures were strongly positive for markers of luminal 
cells like CD8/18, in a few cases, I observed CK8/18-negative, vimentin-positive areas that 
appeared disordered and invasive which might reflect illicit-dedifferentiation. Furthermore, 
the study of regenerative capacity and morphological changes can be combined with further in 
vitro analysis, like lineage marker expression, functionality and gene expression. Thereby, the 
effects of genetic modulation, treatment with signaling molecules and changes in extracellular 
matrix on the behavior of LP cells can be analyzed in detail. Ultimately, these studies will 
lead to a better understanding of the development of LP-derived breast cancer. 
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Ich erkläre hiermit an Eides statt, 
dass ich die vorliegende Dissertation mit dem Thema  
 
 
 
 
An organotypic assay for the quantification and characterization  
of regenerative primary human mammary epithelial cells 
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